1
|
Coenen M, de Kort FAS, Weaver NA, Kuijf HJ, Aben HP, Bae HJ, Bordet R, Chen CL, Dewenter A, Doeven T, Dondaine T, Duering M, Fang R, van der Giessen RS, Kim J, Kim BJ, de Kort PLM, Koudstaal P, Lee M, Lim JS, Lopes R, van Oostenbrugge RJ, Staals J, Yu KH, Biessels GJ, Biesbroek JM. Strategic white matter hyperintensity locations associated with post-stroke cognitive impairment: a multicenter study in 1568 stroke patients. Int J Stroke 2024:17474930241252530. [PMID: 38651756 DOI: 10.1177/17474930241252530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/25/2024]
Abstract
BACKGROUND Post-stroke cognitive impairment (PSCI) occurs in up to 50% of stroke survivors. Presence of pre-existing vascular brain injury, in particular the extent of white matter hyperintensities (WMH), is associated with worse cognitive outcome after stroke, but the role of WMH location in this association is unclear. AIM We determined if WMH in strategic white matter tracts explain cognitive performance after stroke. METHODS Individual patient data from 9 ischemic stroke cohorts with MRI were harmonized through the Meta VCI Map consortium. The association between WMH volumes in strategic tracts and domain-specific cognitive functioning (attention and executive functioning, information processing speed, language and verbal memory) was assessed using linear mixed models and lasso regression. We used a hypothesis-driven design, primarily addressing four white matter tracts known to be strategic in memory clinic patients: the left and right anterior thalamic radiation, forceps major and left inferior fronto-occipital fasciculus. RESULTS The total study sample consisted of 1568 patients (39.9% female, mean age: 67.3 years). Total WMH volume was strongly related to cognitive performance on all four cognitive domains. WMH volume in the left anterior thalamic radiation was significantly associated with cognitive performance on attention and executive functioning and information processing speed, and WMH volume in the forceps major with information processing speed. The multivariable lasso regression showed that these associations were independent of age, sex, education, and total infarct volume and had larger coefficients than total WMH volume. CONCLUSIONS These results show tract-specific relations between WMH volume and cognitive performance after ischemic stroke, independent of total WMH volume. This implies that the concept of strategic lesions in PSCI extends beyond acute infarcts and also involves pre-existing WMH. DATA AVAILABILITY The Meta VCI Map consortium is dedicated to data sharing, following our guidelines.
Collapse
Affiliation(s)
- Mirthe Coenen
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands
- contributed equally
| | - Floor A S de Kort
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands
- contributed equally
| | - Nick A Weaver
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands
| | - Hugo J Kuijf
- Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Hugo Paul Aben
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands
| | - Hee-Joon Bae
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
| | - Régis Bordet
- Lille Neuroscience & Cognition (LilNCog)- U1172, Université Lille, Inserm, CHU Lille, F-59000 Lille, France
| | - Christopher Lh Chen
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore
| | - Anna Dewenter
- Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Germany
| | - Thomas Doeven
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands
| | - Thibaut Dondaine
- 5Lille Neuroscience & Cognition (LilNCog)- U1172, Université Lille, Inserm, CHU Lille, F-59000 Lille, France
| | - Marco Duering
- 8Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Germany
- Medical Image Analysis Center (MIAC) and Department of Biomedical Engineering, University of Basel, Basel, Switzerland
| | - Rong Fang
- Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Germany
| | | | - Jonguk Kim
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
- Department of Neurology, Inha University School of Medicine, Incheon, Republic of Korea
| | - Beom Joon Kim
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
| | - Paul L M de Kort
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands
| | - Peter Koudstaal
- Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Minwoo Lee
- Department of Neurology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea
| | - Jae-Sung Lim
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Renaud Lopes
- Lille Neuroscience & Cognition (LilNCog)- U1172, Université Lille, Inserm, CHU Lille, F-59000 Lille, France
| | | | - Julie Staals
- Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands
| | - Kyung-Ho Yu
- Department of Neurology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea
| | - Geert Jan Biessels
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands
| | - J Matthijs Biesbroek
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands
- contributed equally
| |
Collapse
|
2
|
Caron C, Dondaine T, Bastien A, Chérot N, Deheul S, Gautier S, Cottencin O, Moreau-Crépeaux S, Bordet R, Carton L. Could psychostimulant drug use among university students be related to ADHD symptoms? A preliminary study. Psychiatry Res 2024; 331:115630. [PMID: 38043409 DOI: 10.1016/j.psychres.2023.115630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Revised: 11/20/2023] [Accepted: 11/24/2023] [Indexed: 12/05/2023]
Abstract
We aimed to explore if psychostimulant use among student could be linked to attention deficit-hyperactivity disorder (ADHD) symptoms using a self-administered questionnaire sent by email to French students in 2021. Participants were asked about their psychostimulant use and the presence of ADHD symptoms using the Wender Utah Rating Scale and the Adult Self-Report Scale. Among the 4431 respondents, the prevalence of psychostimulant use was concerning and significantly associated with ADHD symptoms. This association could be related to undiagnosed ADHD or to psychobehavioral impairments induced by psychostimulant use underlining the need of ADHD screening and targeted prevention measures.
Collapse
Affiliation(s)
- Clément Caron
- Pharmacology Department, Psychiatry and Addiction Medicine Department, CHU Lille, Addictovigilance Center, Lille F-59000, France
| | - Thibaut Dondaine
- Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, Pharmacology Department, University of Lille, Inserm, CHU Lille, UMR-S1172, Lille F-59000, France
| | - Axel Bastien
- Psychiatry and Addiction Medicine Department, CHU Lille, Lille F-59000, France
| | - Nathalie Chérot
- University of Lille, CHU Lille, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, Lille F-59000, France
| | - Sylvie Deheul
- Pharmacology Department, CHU Lille, Addictovigilance Center, France
| | - Sophie Gautier
- Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, Pharmacology Department, University of Lille, Inserm, CHU Lille, UMR-S1172, Lille F-59000, France
| | - Olivier Cottencin
- Department of Psychiatry and Addiction Medicine, Plasticity & SubjectivitY (PSY) team, Lille Neuroscience & Cognition Centre (LiNC), CHU Lille, INSERM U-1172, France
| | | | - Régis Bordet
- Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, Pharmacology Department, University of Lille, Inserm, CHU Lille, UMR-S1172, Lille F-59000, France
| | - Louise Carton
- Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, Pharmacology Department, University of Lille, Inserm, CHU Lille, UMR-S1172, Lille F-59000, France.
| |
Collapse
|
3
|
Carton L, Bastien A, Chérot N, Caron C, Deheul S, Cottencin O, Gautier S, Moreau-Crépeaux S, Dondaine T, Bordet R. An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study. Dialogues Clin Neurosci 2023; 25:101-111. [PMID: 37837439 PMCID: PMC10578082 DOI: 10.1080/19585969.2023.2268063] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Accepted: 10/03/2023] [Indexed: 10/16/2023]
Abstract
OBJECTIVES Students represent a population at risk for substance abuse. That risk may have been exacerbated by the COVID-19 pandemic. We aimed to describe substance abuse among students and to compare consumption according to the university field. METHODS A self-administered questionnaire was sent by email to all students at the University of Lille, France, between March and July 2021. This anonymous questionnaire included questions about sociodemographic characteristics, university courses and the use of psychoactive substances (frequency, reasons, routes of administration) since the first university year. RESULTS Among the 4431 students who responded (response rate 6.1%), eighty percent declared having used alcohol since the first university year, 34% cannabis, 15.4% benzodiazepines, 14.7% opioid drugs, 7.5% cocaine, 6.8% nitrous oxide and 6.5% MDMA. More than 20% of the users of cannabis, benzodiazepines, amphetamines and cocaine reported having already felt dependent. Recreational use was described by more than 10% of benzodiazepine or opioid drug users. Nitrous oxide use was significantly more frequent in the health and sport field (p < 0.001). Tobacco, benzodiazepine, cannabis and MDMA uses were significantly more frequent in the humanities and social sciences/art, language and literature fields (p < 0.001). CONCLUSION Prevention measures focusing on alcohol, cannabis, illicit psychostimulants, nitrous oxide and prescription drugs are required in the student population.
Collapse
Affiliation(s)
- Louise Carton
- Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France
| | - Axel Bastien
- Department of Psychiatry and Addiction Medicine, CHU Lille, Lille, France
| | - Nathalie Chérot
- Department of Occupational Health, Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMP ECS - IMPact de l‘Environnement Chimique sur la Santé humaine, Lille, France
| | - Clément Caron
- Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France
- Department of Psychiatry and Addiction Medicine, CHU Lille, Lille, France
| | - Sylvie Deheul
- Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France
| | - Olivier Cottencin
- Department of Psychiatry and Addiction Medicine, Univ Lille, CHU Lille, INSERM U-1172, Plasticity & SubjectivitY (P SY) team, Lille Neuroscience & Cognition Centre (LiNC), Lille, France
| | - Sophie Gautier
- Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France
| | | | - Thibaut Dondaine
- Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France
| | - Régis Bordet
- Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France
| |
Collapse
|
4
|
Millet B, Mouchabac S, Robert G, Maatoug R, Dondaine T, Ferreri F, Bourla A. Transcranial Magnetic Stimulation (rTMS) on the Precuneus in Alzheimer's Disease: A Literature Review. Brain Sci 2023; 13:1332. [PMID: 37759933 PMCID: PMC10526400 DOI: 10.3390/brainsci13091332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Revised: 09/10/2023] [Accepted: 09/14/2023] [Indexed: 09/29/2023] Open
Abstract
The current literature review aimed to evaluate the effectiveness of rTMS on the precuneus as a potential treatment for Alzheimer's disease (AD). Although the number of studies specifically targeting the precuneus is limited, the results from this review suggest the potential benefits of this approach. Future studies should focus on exploring the long-term effects of rTMS on the precuneus in Alzheimer's disease patients, as well as determining the optimal stimulation parameters and protocols for this population. Additionally, investigating the effects of rTMS on the precuneus in combination with other brain regions implicated in AD may provide valuable insights into the development of effective treatment for this debilitating neurodegenerative disorder.
Collapse
Affiliation(s)
- Bruno Millet
- Service de Psychiatrie Adulte de la Pitié-Salpêtrière, Institut du Cerveau, ICM, Sorbonne Université, AP-HP, 75013 Paris, France; (B.M.)
- ICRIN Psychiatry (Infrastructure of Clinical Research in Neurosciences-Psychiatry), Brain Institute (ICM), INSERM, CNRS, 75013 Paris, France; (S.M.); (F.F.)
| | - Stéphane Mouchabac
- ICRIN Psychiatry (Infrastructure of Clinical Research in Neurosciences-Psychiatry), Brain Institute (ICM), INSERM, CNRS, 75013 Paris, France; (S.M.); (F.F.)
- Department of Psychiatry, Hôpital Saint-Antoine, Sorbonne Université, AP-HP, 75012 Paris, France
| | - Gabriel Robert
- Pôle Hospitalo-Universitaire de Psychiatrie Adulte, Centre Hospitalier Guillaume Régnier, 35000 Rennes, France
- U1228 Empenn, UMR 6074 IRISA, Campus de Beaulieu, 35042 Rennes, France
| | - Redwan Maatoug
- Service de Psychiatrie Adulte de la Pitié-Salpêtrière, Institut du Cerveau, ICM, Sorbonne Université, AP-HP, 75013 Paris, France; (B.M.)
- ICRIN Psychiatry (Infrastructure of Clinical Research in Neurosciences-Psychiatry), Brain Institute (ICM), INSERM, CNRS, 75013 Paris, France; (S.M.); (F.F.)
| | - Thibaut Dondaine
- Neuroscience et Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S 1172, INSERM, 59000 Lille, France
| | - Florian Ferreri
- ICRIN Psychiatry (Infrastructure of Clinical Research in Neurosciences-Psychiatry), Brain Institute (ICM), INSERM, CNRS, 75013 Paris, France; (S.M.); (F.F.)
- Department of Psychiatry, Hôpital Saint-Antoine, Sorbonne Université, AP-HP, 75012 Paris, France
| | - Alexis Bourla
- ICRIN Psychiatry (Infrastructure of Clinical Research in Neurosciences-Psychiatry), Brain Institute (ICM), INSERM, CNRS, 75013 Paris, France; (S.M.); (F.F.)
- Department of Psychiatry, Hôpital Saint-Antoine, Sorbonne Université, AP-HP, 75012 Paris, France
- Medical Strategy and Innovation Department, Clariane, 75008 Paris, France
- NeuroStim Psychiatry Practice, 75005 Paris, France
| |
Collapse
|
5
|
Lo JW, Crawford JD, Desmond DW, Bae HJ, Lim JS, Godefroy O, Roussel M, Köhler S, Staals J, Verhey F, Chen C, Xu X, Chong E, Kandiah N, Bordet R, Dondaine T, Mendyk AM, Brodaty H, Traykov L, Mehrabian S, Petrova N, Lipnicki DM, Pan Lam BC, Sachdev PS. Short-term Trajectories of Poststroke Cognitive Function: A STROKOG Collaboration Study. Neurology 2023:WNL.0000000000207281. [PMID: 37072222 DOI: 10.1212/wnl.0000000000207281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Accepted: 02/27/2023] [Indexed: 04/20/2023] Open
Abstract
BACKGROUND AND OBJECTIVES Past studies on post-stroke cognitive function have focused on the average performance or change over time, but few have investigated patterns of cognitive trajectories after stroke. This project used latent class growth analysis (LCGA) to identify clusters of patients with similar patterns of cognition scores over the first-year post-stroke and the extent to which long-term cognitive outcome is predicted by the clusters ("trajectory groups"). METHODS Data were sought from the Stroke and Cognition consortium (STROKOG). LCGA was used to identify clusters of trajectories based on standardized global cognition scores at baseline (T1) and at the 1-year follow-up (T2). One-step IPD meta-analysis was used to examine risk factors for trajectory groups and association of trajectory groups with cognition at the long-term follow-up (T3). RESULTS Nine hospital-based stroke cohorts with 1149 patients (63% male; mean age 66.4 years (SD=11.0)) were included. The median time assessed at T1 was 3.6 months post-stroke, 1.0 year at T2 and 3.2 years at T3. LCGA identified 3 trajectory groups, which were characterized by different mean levels of cognition scores at T1 (low-, -3.27SD (0.94), 17%; medium-, -1.23SD (0.68), 48%; and high-performance, 0.71SD (0.77), 35%). There was significant improvement in cognition for the high-performance group (0.22 SD/year, 95% CI 0.07, 0.36), but changes for the low and medium performance groups were not significant (-0.10 SD/year, 95% CI -0.33, 0.13; 0.11 SD/year, 95% CI -0.08, 0.24 respectively). Factors associated with the low- (versus high-) performance group include age (relative risk ratio [RRR] 1.18, 95% CI 1.14, 1.23), years of education (RRR 0.61, 95% CI 0.56, 0.67), diabetes (RRR 3.78, 95% CI 2.08, 6.88), large artery versus small vessel strokes (RRR 2.77, 95% CI 1.32, 5.83), and moderate/severe strokes (RRR 3.17, 95% 1.42, 7.08). Trajectory groups were predictive of global cognition at T3, but its predictive power was comparable to scores at T1. CONCLUSION The trajectory of cognitive function over the first-year post-stroke is heterogenous. Baseline cognitive function ∼3.6 months post-stroke is a good predictor of long-term cognitive outcome. Older age, lower levels of education, diabetes, large artery strokes, and greater stroke severity are risk factors for lower cognitive performance over the first year.
Collapse
Affiliation(s)
- Jessica W Lo
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia
| | - John D Crawford
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia
| | | | - Hee-Joon Bae
- Department of Neurology, Seoul National University School of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
| | - Jae-Sung Lim
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Olivier Godefroy
- Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France
| | - Martine Roussel
- Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France
| | - Sebastian Köhler
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Alzheimer Center Limburg, Maastricht University, The Netherlands
| | - Julie Staals
- Department of Neurology, School for Cardiovascular diseases (CARIM), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands
| | - Frans Verhey
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Alzheimer Center Limburg, Maastricht University, The Netherlands
| | - Christopher Chen
- Memory Aging and Cognition Centre, Departments of Pharmacology and Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Xin Xu
- Memory Aging and Cognition Centre, Departments of Pharmacology and Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
- The Second Affiliated Hospital and School of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Eddie Chong
- Memory Aging and Cognition Centre, Departments of Pharmacology and Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Nagaendran Kandiah
- National Neuroscience Institute, Singapore
- Duke-NUS Medical School, Singapore
| | - Regis Bordet
- University of Lille, Inserm, CHU de Lille, Lille Neuroscience and Cognition. F-59000 Lille, France
| | - Thibaut Dondaine
- University of Lille, Inserm, CHU de Lille, Lille Neuroscience and Cognition. F-59000 Lille, France
| | - Anne-Marie Mendyk
- University of Lille, Inserm, CHU de Lille, Lille Neuroscience and Cognition. F-59000 Lille, France
| | - Henry Brodaty
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia
- Dementia Collaborative Research Centre, UNSW Medicine, UNSW, Sydney, Australia
| | - Latchezar Traykov
- Clinic of Neurology, UH "Alexandrovska", Medical University - Sofia, Bulgaria
| | - Shima Mehrabian
- Clinic of Neurology, UH "Alexandrovska", Medical University - Sofia, Bulgaria
| | | | | | - Ben Chun Pan Lam
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia
| | - Perminder S Sachdev
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia
- Dementia Collaborative Research Centre, UNSW Medicine, UNSW, Sydney, Australia
| |
Collapse
|
6
|
Biesbroek JM, Weaver NA, Aben HP, Kuijf HJ, Abrigo J, Bae HJ, Barbay M, Best JG, Bordet R, Chappell FM, Chen CPLH, Dondaine T, van der Giessen RS, Godefroy O, Gyanwali B, Hamilton OKL, Hilal S, Huenges Wajer IMC, Kang Y, Kappelle LJ, Kim BJ, Köhler S, de Kort PLM, Koudstaal PJ, Kuchcinski G, Lam BYK, Lee BC, Lee KJ, Lim JS, Lopes R, Makin SDJ, Mendyk AM, Mok VCT, Oh MS, van Oostenbrugge RJ, Roussel M, Shi L, Staals J, Valdés-Hernández MDC, Venketasubramanian N, Verhey FRJ, Wardlaw JM, Werring DJ, Xin X, Yu KH, van Zandvoort MJE, Zhao L, Biessels GJ. Network impact score is an independent predictor of post-stroke cognitive impairment: A multicenter cohort study in 2341 patients with acute ischemic stroke. Neuroimage Clin 2022; 34:103018. [PMID: 35504223 PMCID: PMC9079101 DOI: 10.1016/j.nicl.2022.103018] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Revised: 03/14/2022] [Accepted: 04/22/2022] [Indexed: 11/21/2022]
Abstract
BACKGROUND Post-stroke cognitive impairment (PSCI) is a common consequence of stroke. Accurate prediction of PSCI risk is challenging. The recently developed network impact score, which integrates information on infarct location and size with brain network topology, may improve PSCI risk prediction. AIMS To determine if the network impact score is an independent predictor of PSCI, and of cognitive recovery or decline. METHODS We pooled data from patients with acute ischemic stroke from 12 cohorts through the Meta VCI Map consortium. PSCI was defined as impairment in ≥ 1 cognitive domain on neuropsychological examination, or abnormal Montreal Cognitive Assessment. Cognitive recovery was defined as conversion from PSCI < 3 months post-stroke to no PSCI at follow-up, and cognitive decline as conversion from no PSCI to PSCI. The network impact score was related to serial measures of PSCI using Generalized Estimating Equations (GEE) models, and to PSCI stratified according to post-stroke interval (<3, 3-12, 12-24, >24 months) and cognitive recovery or decline using logistic regression. Models were adjusted for age, sex, education, prior stroke, infarct volume, and study site. RESULTS We included 2341 patients with 4657 cognitive assessments. PSCI was present in 398/844 patients (47%) <3 months, 709/1640 (43%) at 3-12 months, 243/853 (28%) at 12-24 months, and 208/522 (40%) >24 months. Cognitive recovery occurred in 64/181 (35%) patients and cognitive decline in 26/287 (9%). The network impact score predicted PSCI in the univariable (OR 1.50, 95%CI 1.34-1.68) and multivariable (OR 1.27, 95%CI 1.10-1.46) GEE model, with similar ORs in the logistic regression models for specified post-stroke intervals. The network impact score was not associated with cognitive recovery or decline. CONCLUSIONS The network impact score is an independent predictor of PSCI. As such, the network impact score may contribute to a more precise and individualized cognitive prognostication in patients with ischemic stroke. Future studies should address if multimodal prediction models, combining the network impact score with demographics, clinical characteristics and other advanced brain imaging biomarkers, will provide accurate individualized prediction of PSCI. A tool for calculating the network impact score is freely available at https://metavcimap.org/features/software-tools/lsm-viewer/.
Collapse
Affiliation(s)
- J Matthijs Biesbroek
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands.
| | - Nick A Weaver
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands
| | - Hugo P Aben
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands
| | - Hugo J Kuijf
- Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Jill Abrigo
- Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong SAR, China
| | - Hee-Joon Bae
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Mélanie Barbay
- Department of Neurology, Amiens University Hospital, Laboratory of Functional Neurosciences (UR UPJV 4559), Jules Verne Picardy University, 80054 Amiens Cedex, France
| | - Jonathan G Best
- Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, Russell Square House, 10 - 12 Russell Square, London WC1B 5EH, UK
| | - Régis Bordet
- Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France
| | - Francesca M Chappell
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK
| | - Christopher P L H Chen
- Department of Pharmacology, National University of Singapore, Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore
| | - Thibaut Dondaine
- Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France
| | | | - Olivier Godefroy
- Department of Neurology, Amiens University Hospital, Laboratory of Functional Neurosciences (UR UPJV 4559), Jules Verne Picardy University, 80054 Amiens Cedex, France
| | - Bibek Gyanwali
- Department of Pharmacology, National University of Singapore, Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore
| | - Olivia K L Hamilton
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK
| | - Saima Hilal
- Department of Pharmacology, National University of Singapore, Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore
| | - Irene M C Huenges Wajer
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands; Experimental Psychology, Helmholtz Institute, Utrecht University, the Netherlands
| | - Yeonwook Kang
- Department of Psychology, Hallym University, Chuncheon, South Korea
| | - L Jaap Kappelle
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands
| | - Beom Joon Kim
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Sebastian Köhler
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands
| | - Paul L M de Kort
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands
| | - Peter J Koudstaal
- Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore
| | - Gregory Kuchcinski
- Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France
| | - Bonnie Y K Lam
- Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Margaret Kam Ling Cheung Research Centre for Management of Parkinsonism, Gerald Choa Neuroscience Centre, The Chinese University of Hong Kong, Hong Kong SAR, China
| | - Byung-Chul Lee
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Keon-Joo Lee
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Jae-Sung Lim
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Renaud Lopes
- Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France
| | | | - Anne-Marie Mendyk
- Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France
| | - Vincent C T Mok
- Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Margaret Kam Ling Cheung Research Centre for Management of Parkinsonism, Gerald Choa Neuroscience Centre, The Chinese University of Hong Kong, Hong Kong SAR, China
| | - Mi Sun Oh
- Department of Neurology, Hallym University Sacred Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, South Korea
| | | | - Martine Roussel
- Department of Neurology, Amiens University Hospital, Laboratory of Functional Neurosciences (UR UPJV 4559), Jules Verne Picardy University, 80054 Amiens Cedex, France
| | - Lin Shi
- Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong SAR, China; BrainNow Research Institute, Shenzhen, Guangdong Province, China
| | - Julie Staals
- Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands
| | - Maria Del C Valdés-Hernández
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK
| | | | - Frans R J Verhey
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands
| | - Joanna M Wardlaw
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK
| | - David J Werring
- Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, Russell Square House, 10 - 12 Russell Square, London WC1B 5EH, UK
| | - Xu Xin
- Department of Pharmacology, National University of Singapore, Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore
| | - Kyung-Ho Yu
- Department of Neurology, Hallym University Sacred Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, South Korea
| | - Martine J E van Zandvoort
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands; Experimental Psychology, Helmholtz Institute, Utrecht University, the Netherlands
| | - Lei Zhao
- BrainNow Research Institute, Shenzhen, Guangdong Province, China
| | - Geert Jan Biessels
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands
| |
Collapse
|
7
|
Domain L, Guillery M, Linz N, König A, Batail JM, David R, Corouge I, Bannier E, Ferré JC, Dondaine T, Drapier D, Robert GH. Multimodal MRI cerebral correlates of verbal fluency switching and its impairment in women with depression. Neuroimage Clin 2022; 33:102910. [PMID: 34942588 PMCID: PMC8713114 DOI: 10.1016/j.nicl.2021.102910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2021] [Revised: 12/03/2021] [Accepted: 12/04/2021] [Indexed: 11/28/2022]
Abstract
BACKGROUND The search of biomarkers in the field of depression requires easy implementable tests that are biologically rooted. Qualitative analysis of verbal fluency tests (VFT) are good candidates, but its cerebral correlates are unknown. METHODS We collected qualitative semantic and phonemic VFT scores along with grey and white matter anatomical MRI of depressed (n = 26) and healthy controls (HC, n = 25) women. Qualitative VFT variables are the "clustering score" (i.e. the ability to produce words within subcategories) and the "switching score" (i.e. the ability to switch between clusters). The clustering and switching scores were automatically calculated using a data-driven approach. Brain measures were cortical thickness (CT) and fractional anisotropy (FA). We tested for associations between CT, FA and qualitative VFT variables within each group. RESULTS Patients had reduced switching VFT scores compared to HC. Thicker cortex was associated with better switching score in semantic VFT bilaterally in the frontal (superior, rostral middle and inferior gyri), parietal (inferior parietal lobule including the supramarginal gyri), temporal (transverse and fusiform gyri) and occipital (lingual gyri) lobes in the depressed group. Positive association between FA and the switching score in semantic VFT was retrieved in depressed patients within the corpus callosum, right inferior fronto-occipital fasciculus, right superior longitudinal fasciculus extending to the anterior thalamic radiation (all p < 0.05, corrected). CONCLUSION Together, these results suggest that automatic qualitative VFT scores are associated with brain anatomy and reinforce its potential use as a surrogate for depression cerebral bases.
Collapse
Affiliation(s)
- L Domain
- Universitary Department of Psychiatry, Centre Hospitalier Guillaume Régnier, Rennes, France
| | - M Guillery
- Universitary Department of Psychiatry, Centre Hospitalier Guillaume Régnier, Rennes, France
| | - N Linz
- ki:elements, Saarbrücken, Germany
| | - A König
- Stars Team, Institut National de Recherche en Informatique et en Automatique (INRIA), Sophia Antipolis, France; CoBTeK (Cognition-Behaviour-Technology) Lab, FRIS-University Côte d'Azur, Nice, France
| | - J M Batail
- Universitary Department of Psychiatry, Centre Hospitalier Guillaume Régnier, Rennes, France
| | - R David
- Old-age Psychiatry DEPARTMENT, Geriatry Division, University of Nice, France
| | - I Corouge
- U1228 Empenn, UMR 6074, IRISA, University of Rennes 1, France
| | - E Bannier
- U1228 Empenn, UMR 6074, IRISA, University of Rennes 1, France
| | - J C Ferré
- U1228 Empenn, UMR 6074, IRISA, University of Rennes 1, France
| | - T Dondaine
- Univ. Lille, Inserm, CHU Lille, LilNCog, Lille Neuroscience & Cognition, F-59000 Lille, France
| | - D Drapier
- Universitary Department of Psychiatry, Centre Hospitalier Guillaume Régnier, Rennes, France
| | - G H Robert
- Universitary Department of Psychiatry, Centre Hospitalier Guillaume Régnier, Rennes, France; U1228 Empenn, UMR 6074, IRISA, University of Rennes 1, France
| |
Collapse
|
8
|
Sollier-Guillery M, Fortier A, Dondaine T, Batail JM, Robert G, Drapier D, Lacroix A. Emotions and cognitive control: A comparison of bipolar disorder and schizophrenia. Journal of Affective Disorders Reports 2021. [DOI: 10.1016/j.jadr.2021.100251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
9
|
Lo JW, Crawford JD, Desmond DW, Bae HJ, Lim JS, Godefroy O, Roussel M, Kang Y, Jahng S, Köhler S, Staals J, Verhey F, Chen C, Xu X, Chong EJ, Kandiah N, Yatawara C, Bordet R, Dondaine T, Mendyk AM, Brodaty H, Traykov L, Mehrabian S, Petrova N, Kim KW, Bae JB, Han JW, Lipnicki DM, Lam B, Sachdev PS. Long-Term Cognitive Decline After Stroke: An Individual Participant Data Meta-Analysis. Stroke 2021; 53:1318-1327. [PMID: 34775838 DOI: 10.1161/strokeaha.121.035796] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE Poststroke cognitive impairment is common, but the trajectory and magnitude of cognitive decline after stroke is unclear. We examined the course and determinants of cognitive change after stroke using individual participant data from the Stroke and Cognition Consortium. METHODS Nine longitudinal hospital-based cohorts from 7 countries were included. Neuropsychological test scores and normative data were used to calculate standardized scores for global cognition and 5 cognitive domains. One-step individual participant data meta-analysis was used to examine the rate of change in cognitive function and risk factors for cognitive decline after stroke. Stroke-free controls were included to examine rate differences. Based on the literature and our own data that showed short-term improvement in cognitive function after stroke, key analyses were restricted to the period beginning 1-year poststroke to focus on its long-term effects. RESULTS A total of 1488 patients (mean age, 66.3 years; SD, 11.1; 98% ischemic stroke) were followed for a median of 2.68 years (25th-75th percentile: 1.21-4.14 years). After an initial period of improvement through up to 1-year poststroke, decline was seen in global cognition and all domains except executive function after adjusting for age, sex, education, vascular risk factors, and stroke characteristics (-0.053 SD/year [95% CI, -0.073 to -0.033]; P<0.001 for global cognition). Recurrent stroke and older age were associated with faster decline. Decline was significantly faster in patients with stroke compared with controls (difference=-0.078 SD/year [95% CI, -0.11 to -0.045]; P<0.001 for global cognition in a subgroup analysis). CONCLUSIONS Patients with stroke experience cognitive decline that is faster than that of stroke-free controls from 1 to 3 years after onset. An increased rate of decline is associated with older age and recurrent stroke.
Collapse
Affiliation(s)
- Jessica W Lo
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia (J.W.L., J.D.C., H.B., D.M.L., B.L., P.S.S.)
| | - John D Crawford
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia (J.W.L., J.D.C., H.B., D.M.L., B.L., P.S.S.)
| | | | - Hee-Joon Bae
- Department of Neurology, Seoul National University School of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea (H.-J.B.)
| | - Jae-Sung Lim
- Department of Neurology, Asan Medical Center, Seoul, Republic of Korea (J.-S.L., Y.K.)
| | - Olivier Godefroy
- Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France (O.G., M.R.)
| | - Martine Roussel
- Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France (O.G., M.R.)
| | - Yeonwook Kang
- Department of Neurology, Asan Medical Center, Seoul, Republic of Korea (J.-S.L., Y.K.).,Department of Psychology, Hallym University, Republic of Korea (Y.K.)
| | - Seungmin Jahng
- Department of Psychology, Sungkyunkwan University, Republic of Korea (S.J.)
| | - Sebastian Köhler
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Alzheimer Center Limburg, Maastricht University, The Netherlands (S.K., F.V.)
| | - Julie Staals
- Department of Neurology, School for Cardiovascular diseases (CARIM), Maastricht University Medical Center (MUMC+), The Netherlands (J.S.)
| | - Frans Verhey
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Alzheimer Center Limburg, Maastricht University, The Netherlands (S.K., F.V.)
| | - Christopher Chen
- Memory Aging and Cognition Centre, Departments of Pharmacology and Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore (C.C., E.J.C.)
| | - Xin Xu
- The Second Affiliated Hospital and School of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (X.X.)
| | - Eddie J Chong
- Memory Aging and Cognition Centre, Departments of Pharmacology and Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore (C.C., E.J.C.)
| | - Nagaendran Kandiah
- National Neuroscience Institute, Singapore (N.K., C.Y.).,Duke-NUS Medical School, Singapore (N.K.)
| | | | - Régis Bordet
- University of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, France (R.B., T.D., A.-M.M.)
| | - Thibaut Dondaine
- University of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, France (R.B., T.D., A.-M.M.)
| | - Anne-Marie Mendyk
- University of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, France (R.B., T.D., A.-M.M.)
| | - Henry Brodaty
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia (J.W.L., J.D.C., H.B., D.M.L., B.L., P.S.S.).,Dementia Collaborative Research Centre, UNSW Medicine, UNSW, Sydney, Australia (H.B., P.S.S.)
| | - Latchezar Traykov
- Clinic of Neurology, UH "Alexandrovska", Medical University - Sofia, Bulgaria (L.T., S.M.)
| | - Shima Mehrabian
- Clinic of Neurology, UH "Alexandrovska", Medical University - Sofia, Bulgaria (L.T., S.M.)
| | - Neli Petrova
- Kaneff University Hospital, Ruse, Bulgaria (N.P.)
| | - Ki Woong Kim
- Department of Brain and Cognitive Science, Seoul National University College of Natural Sciences, Republic of Korea (K.W.K.).,Department of Psychiatry, Seoul National University, College of Medicine, Republic of Korea (K.W.K.).,Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea (K.W.K., J.B.B., J.W.H.)
| | - Jong Bin Bae
- Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea (K.W.K., J.B.B., J.W.H.)
| | - Ji Won Han
- Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea (K.W.K., J.B.B., J.W.H.)
| | - Darren M Lipnicki
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia (J.W.L., J.D.C., H.B., D.M.L., B.L., P.S.S.)
| | - Ben Lam
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia (J.W.L., J.D.C., H.B., D.M.L., B.L., P.S.S.)
| | - Perminder S Sachdev
- Centre for Healthy Brain Ageing (CHeBA), UNSW, Sydney, Australia (J.W.L., J.D.C., H.B., D.M.L., B.L., P.S.S.).,Dementia Collaborative Research Centre, UNSW Medicine, UNSW, Sydney, Australia (H.B., P.S.S.)
| | | |
Collapse
|
10
|
Péran P, Salabert AS, Dondaine T, Leclerc X, Gros-Dagnac H, Ranjeva JP, Lopes R, Lanteaume L, Blin O, Thalamas C, Bordet R, Payoux P. Functional connectivity and cognitive changes after donepezil treatment in healthy participants. Psychopharmacology (Berl) 2021; 238:3071-3082. [PMID: 34370064 DOI: 10.1007/s00213-021-05923-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2020] [Accepted: 07/06/2021] [Indexed: 10/20/2022]
Abstract
RATIONALE Donepezil is a potent, noncompetitive, reversible, clinically effective acetylcholinesterase inhibitor. The effects of this drug on healthy brains have seldom been investigated. OBJECTIVES The primary objective of the present study was to identify possible functional connectivity markers of the effect of donepezil in healthy young adult volunteers. METHODS The study had a double-blind, randomized, crossover design. 30 healthy adult volunteers underwent resting-state MRI scans during 15 days of donepezil or placebo treatment, in accordance with the design. RESULTS Results showed significant differences in intrinsic functional connectivity between donepezil and placebo, mainly in the right executive control network (RECN). More specifically, we found a decrease in the connectivity of the right inferior parietal node with other RECN nodes. Analysis using the cingulate cortex and parahippocampal regions as seeds also revealed complex modulation of functional connectivity in the donepezil condition. CONCLUSIONS In conclusion, donepezil treatment for 15 days may result in reorganization of resting-state networks, compared with placebo.
Collapse
Affiliation(s)
- P Péran
- Toulouse NeuroImaging Center (ToNIC), Université de Toulouse, INSERM, UPS, 31024, Toulouse Cedex 3, France.
| | - A S Salabert
- Toulouse NeuroImaging Center (ToNIC), Université de Toulouse, INSERM, UPS, 31024, Toulouse Cedex 3, France
| | - T Dondaine
- Degenerative & Vascular Cognitive Disorders Research Unit, INSERM-Lille University-Lille University Hospital, Lille, France
| | - X Leclerc
- Degenerative & Vascular Cognitive Disorders Research Unit, INSERM-Lille University-Lille University Hospital, Lille, France
| | - H Gros-Dagnac
- Toulouse NeuroImaging Center (ToNIC), Université de Toulouse, INSERM, UPS, 31024, Toulouse Cedex 3, France
| | - J-P Ranjeva
- Centre for Metabolic Exploration by Magnetic Resonance (CEMEREM), Aix-Marseille University-CNRS-CRMBM-Timone University Hospital, Marseille, France
| | - R Lopes
- Degenerative & Vascular Cognitive Disorders Research Unit, INSERM-Lille University-Lille University Hospital, Lille, France
| | - L Lanteaume
- Centre for Metabolic Exploration by Magnetic Resonance (CEMEREM), Aix-Marseille University-CNRS-CRMBM-Timone University Hospital, Marseille, France.,Department of Clinical Pharmacology (UPCET), Aix-Marseille University-INSERM-Timone University Hospital, Marseille, France
| | - O Blin
- Centre for Metabolic Exploration by Magnetic Resonance (CEMEREM), Aix-Marseille University-CNRS-CRMBM-Timone University Hospital, Marseille, France.,Department of Clinical Pharmacology (UPCET), Aix-Marseille University-INSERM-Timone University Hospital, Marseille, France
| | - C Thalamas
- Clinical Investigation Center (CIC1436), Toulouse, France
| | - R Bordet
- Degenerative & Vascular Cognitive Disorders Research Unit, INSERM-Lille University-Lille University Hospital, Lille, France
| | - P Payoux
- Toulouse NeuroImaging Center (ToNIC), Université de Toulouse, INSERM, UPS, 31024, Toulouse Cedex 3, France
| | | |
Collapse
|
11
|
Weaver NA, Kuijf HJ, Aben HP, Abrigo J, Bae HJ, Barbay M, Best JG, Bordet R, Chappell FM, Chen CPLH, Dondaine T, van der Giessen RS, Godefroy O, Gyanwali B, Hamilton OKL, Hilal S, Huenges Wajer IMC, Kang Y, Kappelle LJ, Kim BJ, Köhler S, de Kort PLM, Koudstaal PJ, Kuchcinski G, Lam BYK, Lee BC, Lee KJ, Lim JS, Lopes R, Makin SDJ, Mendyk AM, Mok VCT, Oh MS, van Oostenbrugge RJ, Roussel M, Shi L, Staals J, Del C Valdés-Hernández M, Venketasubramanian N, Verhey FRJ, Wardlaw JM, Werring DJ, Xin X, Yu KH, van Zandvoort MJE, Zhao L, Biesbroek JM, Biessels GJ. Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts. Lancet Neurol 2021; 20:448-459. [PMID: 33901427 DOI: 10.1016/s1474-4422(21)00060-0] [Citation(s) in RCA: 105] [Impact Index Per Article: 35.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2020] [Revised: 01/24/2021] [Accepted: 02/12/2021] [Indexed: 12/30/2022]
Abstract
BACKGROUND Post-stroke cognitive impairment (PSCI) occurs in approximately half of people in the first year after stroke. Infarct location is a potential determinant of PSCI, but a comprehensive map of strategic infarct locations predictive of PSCI is unavailable. We aimed to identify infarct locations most strongly predictive of PSCI after acute ischaemic stroke and use this information to develop a prediction model. METHODS In this large-scale multicohort lesion-symptom mapping study, we pooled and harmonised individual patient data from 12 cohorts through the Meta-analyses on Strategic Lesion Locations for Vascular Cognitive Impairment using Lesion-Symptom Mapping (Meta VCI Map) consortium. The identified cohorts (as of Jan 1, 2019) comprised patients with acute symptomatic infarcts on CT or MRI (with available infarct segmentations) and a cognitive assessment up to 15 months after acute ischaemic stroke onset. PSCI was defined as performance lower than the fifth percentile of local normative data, on at least one cognitive domain on a multidomain neuropsychological assessment or on the Montreal Cognitive Assessment. Voxel-based lesion-symptom mapping (VLSM) was used to calculate voxel-wise odds ratios (ORs) for PSCI that were mapped onto a three-dimensional brain template to visualise PSCI risk per location. For the prediction model of PSCI risk, a location impact score on a 5-point scale was derived from the VLSM results on the basis of the mean voxel-wise coefficient (ln[OR]) within each patient's infarct. We did combined internal-external validation by leave-one-cohort-out cross-validation for all 12 cohorts using logistic regression. Predictive performance of a univariable model with only the location impact score was compared with a multivariable model with addition of other clinical PSCI predictors (age, sex, education, time interval between stroke onset and cognitive assessment, history of stroke, and total infarct volume). Testing of visual ratings was done by three clinicians, and accuracy, inter-rater reliability, and intra-rater reliability were assessed with Cohen's weighted kappa. FINDINGS In our sample of 2950 patients (mean age 66·8 years [SD 11·6]; 1157 [39·2%] women), 1286 (43·6%) had PSCI. We achieved high lesion coverage of the brain in our analyses (86·9%). Infarcts in the left frontotemporal lobes, left thalamus, and right parietal lobe were strongly associated with PSCI (after false discovery rate correction, q<0·01; voxel-wise ORs >20). On cross-validation, the location impact score showed good correspondence, based on visual assessment of goodness of fit, between predicted and observed risk of PSCI across cohorts after adjusting for cohort-specific PSCI occurrence. Cross-validations showed that the location impact score by itself had similar performance to the combined model with other PSCI predictors, while allowing for easy visual assessment. Therefore the univariable model with only the location impact score was selected as the final model. Correspondence between visual ratings and actual location impact score (Cohen's weighted kappa: range 0·88-0·92), inter-rater agreement (0·85-0·87), and intra-rater agreement (for a single rater, 0·95) were all high. INTERPRETATION To the best of our knowledge, this study provides the first comprehensive map of strategic infarct locations associated with risk of PSCI. A location impact score was derived from this map that robustly predicted PSCI across cohorts. Furthermore, we developed a quick and reliable visual rating scale that might in the future be applied by clinicians to identify individual patients at risk of PSCI. FUNDING The Netherlands Organisation for Health Research and Development.
Collapse
Affiliation(s)
- Nick A Weaver
- Department of Neurology and Neurosurgery, University Medical Centre (UMC) Utrecht Brain Center, Utrecht, Netherlands
| | - Hugo J Kuijf
- Image Sciences Institute, UMC Utrecht, Utrecht, Netherlands
| | - Hugo P Aben
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, Netherlands
| | - Jill Abrigo
- Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
| | - Hee-Joon Bae
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Mélanie Barbay
- Department of Neurology, Amiens University Hospital, Laboratory of Functional Neurosciences, Jules Verne Picardy University, Amiens, France
| | - Jonathan G Best
- Stroke Research Centre, Department of Brain Repair and Rehabilitation, University College London Queen Square Institute of Neurology, London, UK
| | - Régis Bordet
- Université Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, Lille, France
| | - Francesca M Chappell
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK
| | - Christopher P L H Chen
- Department of Pharmacology, National University of Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore
| | - Thibaut Dondaine
- Université Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, Lille, France
| | | | - Olivier Godefroy
- Department of Neurology, Amiens University Hospital, Laboratory of Functional Neurosciences, Jules Verne Picardy University, Amiens, France
| | - Bibek Gyanwali
- Department of Pharmacology, National University of Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore
| | - Olivia K L Hamilton
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK
| | - Saima Hilal
- Department of Pharmacology, National University of Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore
| | - Irene M C Huenges Wajer
- Department of Neurology and Neurosurgery, University Medical Centre (UMC) Utrecht Brain Center, Utrecht, Netherlands; Experimental Psychology, Helmholtz Institute, Utrecht University, Netherlands
| | - Yeonwook Kang
- Department of Psychology, Hallym University, Chuncheon, South Korea
| | - L Jaap Kappelle
- Department of Neurology and Neurosurgery, University Medical Centre (UMC) Utrecht Brain Center, Utrecht, Netherlands
| | - Beom Joon Kim
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Sebastian Köhler
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands
| | - Paul L M de Kort
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, Netherlands
| | - Peter J Koudstaal
- Department of Neurology, Erasmus Medical Center, Rotterdam, Netherlands
| | - Gregory Kuchcinski
- Université Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, Lille, France
| | - Bonnie Y K Lam
- Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Margaret Kam Ling Cheung Research Centre for Management of Parkinsonism, Gerald Choa Neuroscience Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
| | - Byung-Chul Lee
- Department of Neurology, Hallym University Sacred Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, South Korea
| | - Keon-Joo Lee
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Jae-Sung Lim
- Department of Neurology, Asan Medical Center, Seoul, South Korea
| | - Renaud Lopes
- Université Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, Lille, France
| | - Stephen D J Makin
- Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
| | - Anne-Marie Mendyk
- Université Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, Lille, France
| | - Vincent C T Mok
- Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Margaret Kam Ling Cheung Research Centre for Management of Parkinsonism, Gerald Choa Neuroscience Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
| | - Mi Sun Oh
- Department of Neurology, Hallym University Sacred Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, South Korea
| | | | - Martine Roussel
- Department of Neurology, Amiens University Hospital, Laboratory of Functional Neurosciences, Jules Verne Picardy University, Amiens, France
| | - Lin Shi
- Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; BrainNow Research Institute, Shenzhen, China
| | - Julie Staals
- Department of Neurology, Maastricht University Medical Center, Maastricht, Netherlands
| | - Maria Del C Valdés-Hernández
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK
| | | | - Frans R J Verhey
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands
| | - Joanna M Wardlaw
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK
| | - David J Werring
- Stroke Research Centre, Department of Brain Repair and Rehabilitation, University College London Queen Square Institute of Neurology, London, UK
| | - Xu Xin
- Department of Pharmacology, National University of Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore
| | - Kyung-Ho Yu
- Department of Neurology, Hallym University Sacred Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, South Korea
| | - Martine J E van Zandvoort
- Department of Neurology and Neurosurgery, University Medical Centre (UMC) Utrecht Brain Center, Utrecht, Netherlands; Experimental Psychology, Helmholtz Institute, Utrecht University, Netherlands
| | - Lei Zhao
- BrainNow Research Institute, Shenzhen, China
| | - J Matthijs Biesbroek
- Department of Neurology and Neurosurgery, University Medical Centre (UMC) Utrecht Brain Center, Utrecht, Netherlands
| | - Geert Jan Biessels
- Department of Neurology and Neurosurgery, University Medical Centre (UMC) Utrecht Brain Center, Utrecht, Netherlands.
| |
Collapse
|
12
|
Riou A, Houvenaghel JF, Dondaine T, Drapier S, Sauleau P, Drapier D, Duprez J, Guillery M, Le Jeune F, Verin M, Robert G. Functional Role of the Cerebellum in Parkinson Disease: A PET Study. Neurology 2021; 96:e2874-e2884. [PMID: 33910940 DOI: 10.1212/wnl.0000000000012036] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Accepted: 03/05/2021] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVES To test for cerebellar involvement in motor and nonmotor impairments in Parkinson disease (PD) and to determine patterns of metabolic correlations with supratentorial brain structures, we correlated clinical motor, cognitive, and psychiatric scales with cerebellar metabolism. METHODS We included 90 patients with PD. Motor, cognitive, and psychiatric domains were assessed, and resting-state 18FDG-PET metabolic imaging was performed. The motor, cognitive, and psychiatric scores were entered separately into a principal component analysis. We looked for correlations between these 3 principal components and cerebellar metabolism. Furthermore, we extracted the mean glucose metabolism value for each significant cerebellar cluster and looked for patterns of cerebrum-cerebellum metabolic correlations. RESULTS Severity of impairment was correlated with increased metabolism in the anterior lobes and vermis (motor domain); the right crus I, crus II, and declive (cognitive domain); and the right crus I and crus II (psychiatric domain). No results survived multiple testing corrections regarding the psychiatric domain. Moreover, we found distributed and overlapping, but not identical, patterns of metabolic correlations for motor and cognitive domains. Specific supratentorial structures (cortical structures, basal ganglia, and thalamus) were strongly correlated with each of the cerebellar clusters. CONCLUSIONS These results confirm the role of the cerebellum in nonmotor domains of PD, with differential but overlapping patterns of metabolic correlations suggesting the involvement of cerebello-thalamo-striatal-cortical loops.
Collapse
Affiliation(s)
- Audrey Riou
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France.
| | - Jean-François Houvenaghel
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France
| | - Thibaut Dondaine
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France
| | - Sophie Drapier
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France
| | - Paul Sauleau
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France
| | - Dominique Drapier
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France
| | - Joan Duprez
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France
| | - Murielle Guillery
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France
| | - Florence Le Jeune
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France
| | - Marc Verin
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France
| | - Gabriel Robert
- From the Department of Neurology (A.R., J.-F.H., S.D., P.S., M.V.) and Reference Center for Rare Intellectual Disability (A.R.), Medical Genetics Department, Rennes University Hospital; Behaviour and Basal Ganglia Research Unit (A.R., J.-F.H., S.D., P.S., D.D., J.D., M.G., F.L.J., M.V., G.R.), University of Rennes, Rennes; Department of Pharmacology (T.D.), INSERM U1171, University of Lille; Department of Psychiatry (D.D., M.G., G.R.), Guillaume Regnier Hospital; and Department of Nuclear Medicine (F.L.J.), Eugene Marquis Centre, Rennes, France
| |
Collapse
|
13
|
Robert G, Bannier E, Comte M, Domain L, Corouge I, Dondaine T, Batail JM, Ferre JC, Fakra E, Drapier D. Multimodal brain imaging connectivity analyses of emotional and motivational deficits in depression among women. J Psychiatry Neurosci 2021; 46:E303-E312. [PMID: 33844485 PMCID: PMC8061737 DOI: 10.1503/jpn.200074] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Revised: 07/28/2020] [Accepted: 11/01/2020] [Indexed: 01/11/2023] Open
Abstract
BACKGROUND Major depressive disorder (MDD) is characterized by impaired cortical-subcortical functional connectivity. Apathy adds to functional impairment, but its cerebral basis in MDD remains unknown. Our objective was to describe impairments in functional connectivity during emotional processing in MDD (with varying levels of congruency and attention), and to determine their correlation with apathy. METHODS We used the Variable Attention Affective Task during functional MRI, followed by diffusion-weighted MRI, to assess 55 right-handed women (30 with MDD and 25 healthy controls) between September 2012 and February 2015. We estimated functional connectivity using generalized psychophysiologic interaction and anatomic connectivity with tract-based spatial statistics. We measured apathy using the Apathy Evaluation Scale. RESULTS We found decreased functional connectivity between the left amygdala and the left anterior cingulate cortex (ACC) during negative stimuli in participants with MDD (t54 = 4.2; p = 0.035, family-wise error [FWE]-corrected). During high-attention stimuli, participants with MDD showed reduced functional connectivity between the right dorsolateral prefrontal cortex (dlPFC) and the right ACC (t54 = 4.06, pFWE = 0.02), but greater functional connectivity between the right dlPFC and the right amygdala (t54 = 3.35, p = 0.048). Apathy was associated with increased functional connectivity between the right dlPFC and the right ACC during high-attention stimuli (t28 = 5.2, p = 0.01) and increased fractional anisotropy in the right posterior cerebellum, the anterior and posterior cingulum and the bilateral internal capsule (all pFWE < 0.05). LIMITATIONS Limitations included a moderate sample size, concomitant antidepressant therapy and no directed connectivity. CONCLUSION We found that MDD was associated with impairments in cortical-subcortical functional connectivity during negative stimuli that might alter the recruitment of networks engaged in attention. Apathy-related features suggested networks similar to those observed in degenerative disorders, but possible different mechanisms.
Collapse
Affiliation(s)
- Gabriel Robert
- From the EA 4712 Comportement et noyaux gris centraux, Université de Rennes 1, France (Robert, Batail, Drapier); the Psychiatry Department, Centre Hospitalier Guillaume Régnier, 108 Boulevard Général Leclerc, 35000, Rennes, France (Robert, Domain, Batail, Drapier); the Radiology Department, CHU Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France (Bannier, Ferre); the University of Rennes, CNRS, Inria, Inserm, IRISA UMR 6074, Empenn-ERL U 1228, 35000 Rennes, France (Bannier, Corouge, Ferre, Barillot); the Institut de Neurosciences de la Timone, Campus Santé Timone, 27, Bd Jean Moulin 13005 Marseille, France (Comte); the University of Lille & CHU Lille, Inserm, U1171, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France (Dondaine); and the Psychiatry Department, CHU Saint-Etienne, Team PsyR2-Centre de Recherche en Neuroscience de Lyon, (CRNL) CNRS UMR 5292-Inserm U1028, University of Lyon and Saint Etienne, France (Fakra)
| | - Elise Bannier
- From the EA 4712 Comportement et noyaux gris centraux, Université de Rennes 1, France (Robert, Batail, Drapier); the Psychiatry Department, Centre Hospitalier Guillaume Régnier, 108 Boulevard Général Leclerc, 35000, Rennes, France (Robert, Domain, Batail, Drapier); the Radiology Department, CHU Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France (Bannier, Ferre); the University of Rennes, CNRS, Inria, Inserm, IRISA UMR 6074, Empenn-ERL U 1228, 35000 Rennes, France (Bannier, Corouge, Ferre, Barillot); the Institut de Neurosciences de la Timone, Campus Santé Timone, 27, Bd Jean Moulin 13005 Marseille, France (Comte); the University of Lille & CHU Lille, Inserm, U1171, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France (Dondaine); and the Psychiatry Department, CHU Saint-Etienne, Team PsyR2-Centre de Recherche en Neuroscience de Lyon, (CRNL) CNRS UMR 5292-Inserm U1028, University of Lyon and Saint Etienne, France (Fakra)
| | - Magali Comte
- From the EA 4712 Comportement et noyaux gris centraux, Université de Rennes 1, France (Robert, Batail, Drapier); the Psychiatry Department, Centre Hospitalier Guillaume Régnier, 108 Boulevard Général Leclerc, 35000, Rennes, France (Robert, Domain, Batail, Drapier); the Radiology Department, CHU Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France (Bannier, Ferre); the University of Rennes, CNRS, Inria, Inserm, IRISA UMR 6074, Empenn-ERL U 1228, 35000 Rennes, France (Bannier, Corouge, Ferre, Barillot); the Institut de Neurosciences de la Timone, Campus Santé Timone, 27, Bd Jean Moulin 13005 Marseille, France (Comte); the University of Lille & CHU Lille, Inserm, U1171, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France (Dondaine); and the Psychiatry Department, CHU Saint-Etienne, Team PsyR2-Centre de Recherche en Neuroscience de Lyon, (CRNL) CNRS UMR 5292-Inserm U1028, University of Lyon and Saint Etienne, France (Fakra)
| | - Lea Domain
- From the EA 4712 Comportement et noyaux gris centraux, Université de Rennes 1, France (Robert, Batail, Drapier); the Psychiatry Department, Centre Hospitalier Guillaume Régnier, 108 Boulevard Général Leclerc, 35000, Rennes, France (Robert, Domain, Batail, Drapier); the Radiology Department, CHU Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France (Bannier, Ferre); the University of Rennes, CNRS, Inria, Inserm, IRISA UMR 6074, Empenn-ERL U 1228, 35000 Rennes, France (Bannier, Corouge, Ferre, Barillot); the Institut de Neurosciences de la Timone, Campus Santé Timone, 27, Bd Jean Moulin 13005 Marseille, France (Comte); the University of Lille & CHU Lille, Inserm, U1171, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France (Dondaine); and the Psychiatry Department, CHU Saint-Etienne, Team PsyR2-Centre de Recherche en Neuroscience de Lyon, (CRNL) CNRS UMR 5292-Inserm U1028, University of Lyon and Saint Etienne, France (Fakra)
| | - Isabelle Corouge
- From the EA 4712 Comportement et noyaux gris centraux, Université de Rennes 1, France (Robert, Batail, Drapier); the Psychiatry Department, Centre Hospitalier Guillaume Régnier, 108 Boulevard Général Leclerc, 35000, Rennes, France (Robert, Domain, Batail, Drapier); the Radiology Department, CHU Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France (Bannier, Ferre); the University of Rennes, CNRS, Inria, Inserm, IRISA UMR 6074, Empenn-ERL U 1228, 35000 Rennes, France (Bannier, Corouge, Ferre, Barillot); the Institut de Neurosciences de la Timone, Campus Santé Timone, 27, Bd Jean Moulin 13005 Marseille, France (Comte); the University of Lille & CHU Lille, Inserm, U1171, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France (Dondaine); and the Psychiatry Department, CHU Saint-Etienne, Team PsyR2-Centre de Recherche en Neuroscience de Lyon, (CRNL) CNRS UMR 5292-Inserm U1028, University of Lyon and Saint Etienne, France (Fakra)
| | - Thibaut Dondaine
- From the EA 4712 Comportement et noyaux gris centraux, Université de Rennes 1, France (Robert, Batail, Drapier); the Psychiatry Department, Centre Hospitalier Guillaume Régnier, 108 Boulevard Général Leclerc, 35000, Rennes, France (Robert, Domain, Batail, Drapier); the Radiology Department, CHU Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France (Bannier, Ferre); the University of Rennes, CNRS, Inria, Inserm, IRISA UMR 6074, Empenn-ERL U 1228, 35000 Rennes, France (Bannier, Corouge, Ferre, Barillot); the Institut de Neurosciences de la Timone, Campus Santé Timone, 27, Bd Jean Moulin 13005 Marseille, France (Comte); the University of Lille & CHU Lille, Inserm, U1171, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France (Dondaine); and the Psychiatry Department, CHU Saint-Etienne, Team PsyR2-Centre de Recherche en Neuroscience de Lyon, (CRNL) CNRS UMR 5292-Inserm U1028, University of Lyon and Saint Etienne, France (Fakra)
| | - Jean-Marie Batail
- From the EA 4712 Comportement et noyaux gris centraux, Université de Rennes 1, France (Robert, Batail, Drapier); the Psychiatry Department, Centre Hospitalier Guillaume Régnier, 108 Boulevard Général Leclerc, 35000, Rennes, France (Robert, Domain, Batail, Drapier); the Radiology Department, CHU Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France (Bannier, Ferre); the University of Rennes, CNRS, Inria, Inserm, IRISA UMR 6074, Empenn-ERL U 1228, 35000 Rennes, France (Bannier, Corouge, Ferre, Barillot); the Institut de Neurosciences de la Timone, Campus Santé Timone, 27, Bd Jean Moulin 13005 Marseille, France (Comte); the University of Lille & CHU Lille, Inserm, U1171, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France (Dondaine); and the Psychiatry Department, CHU Saint-Etienne, Team PsyR2-Centre de Recherche en Neuroscience de Lyon, (CRNL) CNRS UMR 5292-Inserm U1028, University of Lyon and Saint Etienne, France (Fakra)
| | - Jean-Christophe Ferre
- From the EA 4712 Comportement et noyaux gris centraux, Université de Rennes 1, France (Robert, Batail, Drapier); the Psychiatry Department, Centre Hospitalier Guillaume Régnier, 108 Boulevard Général Leclerc, 35000, Rennes, France (Robert, Domain, Batail, Drapier); the Radiology Department, CHU Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France (Bannier, Ferre); the University of Rennes, CNRS, Inria, Inserm, IRISA UMR 6074, Empenn-ERL U 1228, 35000 Rennes, France (Bannier, Corouge, Ferre, Barillot); the Institut de Neurosciences de la Timone, Campus Santé Timone, 27, Bd Jean Moulin 13005 Marseille, France (Comte); the University of Lille & CHU Lille, Inserm, U1171, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France (Dondaine); and the Psychiatry Department, CHU Saint-Etienne, Team PsyR2-Centre de Recherche en Neuroscience de Lyon, (CRNL) CNRS UMR 5292-Inserm U1028, University of Lyon and Saint Etienne, France (Fakra)
| | - Eric Fakra
- From the EA 4712 Comportement et noyaux gris centraux, Université de Rennes 1, France (Robert, Batail, Drapier); the Psychiatry Department, Centre Hospitalier Guillaume Régnier, 108 Boulevard Général Leclerc, 35000, Rennes, France (Robert, Domain, Batail, Drapier); the Radiology Department, CHU Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France (Bannier, Ferre); the University of Rennes, CNRS, Inria, Inserm, IRISA UMR 6074, Empenn-ERL U 1228, 35000 Rennes, France (Bannier, Corouge, Ferre, Barillot); the Institut de Neurosciences de la Timone, Campus Santé Timone, 27, Bd Jean Moulin 13005 Marseille, France (Comte); the University of Lille & CHU Lille, Inserm, U1171, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France (Dondaine); and the Psychiatry Department, CHU Saint-Etienne, Team PsyR2-Centre de Recherche en Neuroscience de Lyon, (CRNL) CNRS UMR 5292-Inserm U1028, University of Lyon and Saint Etienne, France (Fakra)
| | - Dominique Drapier
- From the EA 4712 Comportement et noyaux gris centraux, Université de Rennes 1, France (Robert, Batail, Drapier); the Psychiatry Department, Centre Hospitalier Guillaume Régnier, 108 Boulevard Général Leclerc, 35000, Rennes, France (Robert, Domain, Batail, Drapier); the Radiology Department, CHU Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France (Bannier, Ferre); the University of Rennes, CNRS, Inria, Inserm, IRISA UMR 6074, Empenn-ERL U 1228, 35000 Rennes, France (Bannier, Corouge, Ferre, Barillot); the Institut de Neurosciences de la Timone, Campus Santé Timone, 27, Bd Jean Moulin 13005 Marseille, France (Comte); the University of Lille & CHU Lille, Inserm, U1171, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France (Dondaine); and the Psychiatry Department, CHU Saint-Etienne, Team PsyR2-Centre de Recherche en Neuroscience de Lyon, (CRNL) CNRS UMR 5292-Inserm U1028, University of Lyon and Saint Etienne, France (Fakra)
| |
Collapse
|
14
|
Lopes R, Bournonville C, Kuchcinski G, Dondaine T, Mendyk AM, Viard R, Pruvo JP, Hénon H, Georgakis MK, Duering M, Dichgans M, Cordonnier C, Leclerc X, Bordet R. Prediction of Long-term Cognitive Function After Minor Stroke Using Functional Connectivity. Neurology 2021; 96:e1167-e1179. [PMID: 33402437 DOI: 10.1212/wnl.0000000000011452] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Revised: 09/02/2020] [Accepted: 10/12/2020] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To determine whether functional MRI connectivity can predict long-term cognitive function 36 months after minor stroke. METHODS Seventy-two participants with first-ever stroke were included at baseline and followed up for 36 months. A ridge regression machine learning algorithm was developed and used to predict cognitive scores 36 months poststroke on the basis of the functional networks measured using MRI at 6 months (referred to here as the poststroke cognitive impairment [PSCI] network). The prediction accuracy was evaluated in 4 domains (memory, attention/executive, language, and visuospatial functions) and compared with clinical data and other functional networks. The models' statistical significance was probed with permutation tests. The potential involvement of cortical atrophy was assessed 6 months poststroke. A second, independent dataset (n = 40) was used to validate the results and assess their generalizability. RESULTS Based on the PSCI network, a machine learning model was able to predict memory, attention, visuospatial functions, and language functions 36 months poststroke (r 2: 0.67, 0.73, 0.55, and 0.48, respectively). The PSCI-based model was at least as accurate as models based on other functional networks or clinical data. Specific patterns were demonstrated for the 4 cognitive domains, with involvement of the left superior frontal cortex for memory, attention, and visuospatial functions. The cortical thickness 6 months poststroke was not correlated with cognitive function 36 months poststroke. The independent validation dataset gave similar results. CONCLUSIONS A machine learning model based on the PSCI network can predict long-term cognitive outcome after stroke.
Collapse
Affiliation(s)
- Renaud Lopes
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany.
| | - Clément Bournonville
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Grégory Kuchcinski
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Thibaut Dondaine
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Anne-Marie Mendyk
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Romain Viard
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Jean-Pierre Pruvo
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Hilde Hénon
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Marios K Georgakis
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Marco Duering
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Martin Dichgans
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Charlotte Cordonnier
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Xavier Leclerc
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| | - Régis Bordet
- From U1172-LilNCog-Lille Neuroscience & Cognition (R.L., C.B., G.K., T.D., A.-M.M., J.-P.P., H.H., C.C., X.L., R.B.) and Institut Pasteur de Lille, US 41-UMS 2014-PLBS, CNRS (R.L., C.B., G.K., R.V., J.-P.P., X.L.), CHU Lille, Inserm, Université de Lille, France; and Institute for Stroke and Dementia Research (M.K.G., M. Duering, M. Dichgans), LMU Munich University Hospital, Germany
| |
Collapse
|
15
|
Tang EYH, Price CI, Robinson L, Exley C, Desmond DW, Köhler S, Staals J, Yin Ka Lam B, Wong A, Mok V, Bordet R, Bordet AM, Dondaine T, Lo JW, Sachdev PS, Stephan BCM. Assessing the Predictive Validity of Simple Dementia Risk Models in Harmonized Stroke Cohorts. Stroke 2020; 51:2095-2102. [PMID: 32568644 PMCID: PMC7306263 DOI: 10.1161/strokeaha.120.027473] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Supplemental Digital Content is available in the text. Stroke is associated with an increased risk of dementia. To assist in the early identification of individuals at high risk of future dementia, numerous prediction models have been developed for use in the general population. However, it is not known whether such models also provide accurate predictions among stroke patients. Therefore, the aim of this study was to determine whether existing dementia risk prediction models that were developed for use in the general population can also be applied to individuals with a history of stroke to predict poststroke dementia with equivalent predictive validity.
Collapse
Affiliation(s)
- Eugene Y H Tang
- Population Health Sciences Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle Upon Tyne, United Kingdom (E.Y.H.T., C.I.P., L.R., C.E.)
| | - Christopher I Price
- Population Health Sciences Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle Upon Tyne, United Kingdom (E.Y.H.T., C.I.P., L.R., C.E.)
| | - Louise Robinson
- Population Health Sciences Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle Upon Tyne, United Kingdom (E.Y.H.T., C.I.P., L.R., C.E.)
| | - Catherine Exley
- Population Health Sciences Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle Upon Tyne, United Kingdom (E.Y.H.T., C.I.P., L.R., C.E.)
| | | | - Sebastian Köhler
- School for Mental Health and Neuroscience, Maastricht University, the Netherlands (S.K.)
| | - Julie Staals
- Department of Neurology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, the Netherlands (J.S.)
| | - Bonnie Yin Ka Lam
- Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong SAR (B.Y.K.L., A.W., V.M.)
| | - Adrian Wong
- Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong SAR (B.Y.K.L., A.W., V.M.)
| | - Vincent Mok
- Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong SAR (B.Y.K.L., A.W., V.M.)
| | - Regis Bordet
- University Lille, Inserm, CHU Lille, U1171-Degenerative and Vascular Cognitive Disorders, France (R.B., A.-M.B., T.D.)
| | - Anne-Marie Bordet
- University Lille, Inserm, CHU Lille, U1171-Degenerative and Vascular Cognitive Disorders, France (R.B., A.-M.B., T.D.)
| | - Thibaut Dondaine
- University Lille, Inserm, CHU Lille, U1171-Degenerative and Vascular Cognitive Disorders, France (R.B., A.-M.B., T.D.)
| | - Jessica W Lo
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia (J.W.L., P.S.S.)
| | - Perminder S Sachdev
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia (J.W.L., P.S.S.).,Neuropsychiatric Institute, Prince of Wales Hospital, Sydney (P.S.S.)
| | - Blossom C M Stephan
- Institute of Mental Health, Division of Psychiatry and Applied Psychology, School of Medicine, Nottingham University, UK (B.C.M.S.)
| | | |
Collapse
|
16
|
Lo JW, Crawford JD, Samaras K, Desmond DW, Köhler S, Staals J, Verhey FRJ, Bae HJ, Lee KJ, Kim BJ, Bordet R, Cordonnier C, Dondaine T, Mendyk AM, Lee BC, Yu KH, Lim JS, Kandiah N, Chander RJ, Yatawara C, Lipnicki DM, Sachdev PS. Association of Prediabetes and Type 2 Diabetes With Cognitive Function After Stroke: A STROKOG Collaboration Study. Stroke 2020; 51:1640-1646. [PMID: 32404039 DOI: 10.1161/strokeaha.119.028428] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Background and Purpose- Type 2 diabetes mellitus (T2D) is associated with cognitive impairment and an increased risk of dementia, but the association between prediabetes and cognitive impairment is less clear, particularly in a setting of major cerebrovascular events. This article examines the impact of impaired fasting glucose and T2D on cognitive performance in a stroke population. Methods- Seven international observational studies from the STROKOG (Stroke and Cognition) consortium (n=1601; mean age, 66.0 years; 70% Asian, 26% white, and 2.6% African American) were included. Fasting glucose level (FGL) during hospitalization was used to define 3 groups, T2D (FGL ≥7.0 mmol/L), impaired fasting glucose (FGL 6.1-6.9 mmol/L), and normal (FGL <6.1 mmol/L), and a history of diabetes mellitus and the use of a diabetes mellitus medication were also used to support a diagnosis of T2D. Domain and global cognition Z scores were derived from standardized neuropsychological test scores. The cross-sectional association between glucose status and cognitive performance at 3 to 6 months poststroke was examined using linear mixed models, adjusting for age, sex, education, stroke type, ethnicity, and vascular risk factors. Results- Patients with T2D had significantly poorer performance in global cognition (SD, -0.59 [95% CI, -0.82 to -0.36]; P<0.001) and in all domains compared with patients with normal FGL. There was no significant difference between impaired fasting glucose patients and those with normal FGL in global cognition (SD, -0.10 [95% CI, -0.45 to 0.24]; P=0.55) or in any cognitive domain. Conclusions- Diabetes mellitus, but not prediabetes, is associated with poorer cognitive performance in patients 3 to 6 months after stroke.
Collapse
Affiliation(s)
- Jessica W Lo
- From the Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, UNSW Sydney, Australia (J.W.L., J.D.C., R.J.C., D.M.L., P.S.S.)
| | - John D Crawford
- From the Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, UNSW Sydney, Australia (J.W.L., J.D.C., R.J.C., D.M.L., P.S.S.)
| | - Katherine Samaras
- St. Vincent's Medical School, UNSW Sydney, Australia (K.S.).,Department of Endocrinology, St. Vincent's Hospital, Darlinghurst, Australia (K.S.).,Diabetes Division, Garvan Institute of Medical Research, Darlinghurst, Australia (K.S.)
| | | | - Sebastian Köhler
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, the Netherlands (S.K., F.R.J.V.)
| | - Julie Staals
- Department of Neurology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, the Netherlands (J.S.)
| | - Frans R J Verhey
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, the Netherlands (S.K., F.R.J.V.)
| | - Hee-Joon Bae
- Department of Neurology, Seoul National University College of Medicine, Cerebrovascular Disease Center, Seoul National University Bundang Hospital, Republic of Korea (H.-J.B., K.-J.L., B.J.K.)
| | - Keon-Joo Lee
- Department of Neurology, Seoul National University College of Medicine, Cerebrovascular Disease Center, Seoul National University Bundang Hospital, Republic of Korea (H.-J.B., K.-J.L., B.J.K.)
| | - Beom Joon Kim
- Department of Neurology, Seoul National University College of Medicine, Cerebrovascular Disease Center, Seoul National University Bundang Hospital, Republic of Korea (H.-J.B., K.-J.L., B.J.K.)
| | - Régis Bordet
- University of Lille, Inserm, CHU Lille, U1171-Degenerative and Vascular Cognitive Disorders, France (R.B., C.C., T.D., A.-M.M.)
| | - Charlotte Cordonnier
- University of Lille, Inserm, CHU Lille, U1171-Degenerative and Vascular Cognitive Disorders, France (R.B., C.C., T.D., A.-M.M.)
| | - Thibaut Dondaine
- University of Lille, Inserm, CHU Lille, U1171-Degenerative and Vascular Cognitive Disorders, France (R.B., C.C., T.D., A.-M.M.)
| | - Anne-Marie Mendyk
- University of Lille, Inserm, CHU Lille, U1171-Degenerative and Vascular Cognitive Disorders, France (R.B., C.C., T.D., A.-M.M.)
| | - Byung-Chul Lee
- Department of Neurology, Hallym University Sacred Heart Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, Republic of Korea (B.-C.L., K.-H.Y., J.-S.L.)
| | - Kyung-Ho Yu
- Department of Neurology, Hallym University Sacred Heart Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, Republic of Korea (B.-C.L., K.-H.Y., J.-S.L.)
| | - Jae-Sung Lim
- Department of Neurology, Hallym University Sacred Heart Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, Republic of Korea (B.-C.L., K.-H.Y., J.-S.L.)
| | - Nagaendran Kandiah
- Department of Neurology, National Neuroscience Institute, Singapore (N.K., C.Y.).,Behavioural Disorders Programme, Duke-NUS Medical School, Singapore (N.K.)
| | - Russell J Chander
- From the Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, UNSW Sydney, Australia (J.W.L., J.D.C., R.J.C., D.M.L., P.S.S.)
| | - Chathuri Yatawara
- Department of Neurology, National Neuroscience Institute, Singapore (N.K., C.Y.)
| | - Darren M Lipnicki
- From the Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, UNSW Sydney, Australia (J.W.L., J.D.C., R.J.C., D.M.L., P.S.S.)
| | - Perminder S Sachdev
- From the Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, UNSW Sydney, Australia (J.W.L., J.D.C., R.J.C., D.M.L., P.S.S.).,Dementia Collaborative Research Centre, UNSW Sydney, Australia (P.S.S.)
| | | |
Collapse
|
17
|
Betrouni N, Yasmina M, Bombois S, Pétrault M, Dondaine T, Lachaud C, Laloux C, Mendyk AM, Henon H, Bordet R. Texture Features of Magnetic Resonance Images: an Early Marker of Post-stroke Cognitive Impairment. Transl Stroke Res 2019; 11:643-652. [PMID: 31677092 DOI: 10.1007/s12975-019-00746-3] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2019] [Revised: 10/08/2019] [Accepted: 10/09/2019] [Indexed: 11/26/2022]
Abstract
Stroke is frequently associated with delayed, long-term cognitive impairment (CI) and dementia. Recent research has focused on identifying early predictive markers of CI occurrence. We carried out a texture analysis of magnetic resonance (MR) images to identify predictive markers of CI occurrence based on a combination of preclinical and clinical data. Seventy-two-hour post-stroke T1W MR images of 160 consecutive patients were examined, including 75 patients with confirmed CI at the 6-month post-stroke neuropsychological examination. Texture features were measured in the hippocampus and entorhinal cortex and compared between patients with CI and those without. A correlation study determined their association with MoCA and MMSE clinical scores. Significant features were then combined with the classical prognostic factors, age and gender, to build a machine learning algorithm as a predictive model for CI occurrence. A middle cerebral artery transient occlusion model was used. Texture features were compared in the hippocampus of sham and lesioned rats and were correlated with histologically assessed neural loss. In clinical studies, two texture features, kurtosis and inverse difference moment, differed significantly between patients with and without CI and were significantly correlated with MoCA and MMSE scores. The prediction model had an accuracy of 88 ± 3%. The preclinical model revealed a significant correlation between texture features and neural density in the hippocampus contralateral to the ischemic area. These preliminary results suggest that texture features of MR images are representative of neural alteration and could be a part of a screening strategy for the early prediction of post-stroke CI.
Collapse
Affiliation(s)
- Nacim Betrouni
- Laboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France.
| | - Moussaoui Yasmina
- Laboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France
| | - Stéphanie Bombois
- Laboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France
| | - Maud Pétrault
- Laboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France
| | - Thibaut Dondaine
- Laboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France
| | - Cédrick Lachaud
- Laboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France
| | - Charlotte Laloux
- Laboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France
| | - Anne-Marie Mendyk
- Laboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France
| | - Hilde Henon
- Laboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France
| | - Régis Bordet
- Laboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France
| |
Collapse
|
18
|
Duprez J, Houvenaghel JF, Dondaine T, Péron J, Haegelen C, Drapier S, Modolo J, Jannin P, Vérin M, Sauleau P. Subthalamic nucleus local field potentials recordings reveal subtle effects of promised reward during conflict resolution in Parkinson's disease. Neuroimage 2019; 197:232-242. [DOI: 10.1016/j.neuroimage.2019.04.071] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2018] [Revised: 02/20/2019] [Accepted: 04/26/2019] [Indexed: 10/26/2022] Open
|
19
|
Carton L, Dondaine T, Deheul S, Marquié C, Brigadeau F, Amad A, Devos D, Danel T, Bordet R, Cottencin O, Gautier S, Ménard O. Prescriptions hors AMM supervisées de méthylphénidate dans le TDAH de l’adulte. Encephale 2019; 45:74-81. [DOI: 10.1016/j.encep.2018.05.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2018] [Revised: 05/17/2018] [Accepted: 05/25/2018] [Indexed: 12/16/2022]
|
20
|
Dondaine T, Philippot P, Batail JM, Le Jeune F, Sauleau P, Drapier S, Vérin M, Millet B, Drapier D, Robert G. Apathy alters emotional arousal in chronic schizophrenia. J Psychiatry Neurosci 2019; 44:54-61. [PMID: 30565906 PMCID: PMC6306283 DOI: 10.1503/jpn.170172] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2017] [Revised: 01/10/2018] [Accepted: 05/22/2018] [Indexed: 02/01/2023] Open
Abstract
Background Within the heterogeneity of schizophrenia, apathy constitutes an independent cluster of negative symptoms associated with poor outcomes. Attempts to identify an emotional deficit in patients who have schizophrenia with negative symptoms have yielded mixed results, and studies that focus on the relationship between apathy and emotional disorders are lacking. Methods We set out to remedy this shortcoming using a validated battery of film excerpts to induce positive and negative emotions in patients with chronic schizophrenia with (n = 20) or without (n = 20) apathy, and in controls (n = 20) comparable for age, sex and socioeconomic status. We assessed emotions using an innovative but validated technique to evaluate tonic and phasic electrodermal activity and subjective feelings using a standardized visual analogue scale. Results Using a qualitative measure of apathy, we did not find a specific decrease in tonic activity during the induction of positive emotions. However, we did observe that patients with apathy showed reduced tonic activity independent of valence (i.e., for both positive and negative emotions) compared with controls and patients without apathy. Moreover, the quantitative measure of apathy (Apathy Evaluation Scale) was the only significant factor, explaining 24% of the variance in tonic activity during induction of positive emotions after controlling for confounding factors. Limitations Electrodermal activity was the only physiologic measure we acquired. We induced several emotions sequentially that might have overlapped with each other, but we added an emotional “washout” period and randomized the order of each film excerpt to limit this possibility. Conclusion Taken together, these results suggest that apathy in schizophrenia could impair tonic activity during positive emotions. Treatments aimed at enhancing positive emotions may help alleviate apathy in schizophrenia.
Collapse
Affiliation(s)
- Thibaut Dondaine
- From the University Department of Psychiatry, Guillaume Régnier Hospital, Rennes, France (Batail, D. Drapier, Robert); University of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France (Dondaine); Behaviour and Basal Ganglia Laboratory (EA 4712), University of Rennes, Rennes, France (Batail, Le Jeune, Sauleau, S. Drapier, Vérin, D. Drapier, Robert); Eugène Marquis Centre, Rennes, France (Le Jeune); Neurophysiology Department, Rennes University Hospital, Rennes, France (Sauleau); Movement Disorders Unit, Rennes University Hospital, Rennes, France (S. Drapier, Vérin); Psychiatry Department, Pitié-Salpêtrière Hospital, Paris, France (Millet); University of Louvain-la-Neuve, Louvain-la-Neuve, Belgium (Philippot)
| | - Pierre Philippot
- From the University Department of Psychiatry, Guillaume Régnier Hospital, Rennes, France (Batail, D. Drapier, Robert); University of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France (Dondaine); Behaviour and Basal Ganglia Laboratory (EA 4712), University of Rennes, Rennes, France (Batail, Le Jeune, Sauleau, S. Drapier, Vérin, D. Drapier, Robert); Eugène Marquis Centre, Rennes, France (Le Jeune); Neurophysiology Department, Rennes University Hospital, Rennes, France (Sauleau); Movement Disorders Unit, Rennes University Hospital, Rennes, France (S. Drapier, Vérin); Psychiatry Department, Pitié-Salpêtrière Hospital, Paris, France (Millet); University of Louvain-la-Neuve, Louvain-la-Neuve, Belgium (Philippot)
| | - Jean-Marie Batail
- From the University Department of Psychiatry, Guillaume Régnier Hospital, Rennes, France (Batail, D. Drapier, Robert); University of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France (Dondaine); Behaviour and Basal Ganglia Laboratory (EA 4712), University of Rennes, Rennes, France (Batail, Le Jeune, Sauleau, S. Drapier, Vérin, D. Drapier, Robert); Eugène Marquis Centre, Rennes, France (Le Jeune); Neurophysiology Department, Rennes University Hospital, Rennes, France (Sauleau); Movement Disorders Unit, Rennes University Hospital, Rennes, France (S. Drapier, Vérin); Psychiatry Department, Pitié-Salpêtrière Hospital, Paris, France (Millet); University of Louvain-la-Neuve, Louvain-la-Neuve, Belgium (Philippot)
| | - Florence Le Jeune
- From the University Department of Psychiatry, Guillaume Régnier Hospital, Rennes, France (Batail, D. Drapier, Robert); University of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France (Dondaine); Behaviour and Basal Ganglia Laboratory (EA 4712), University of Rennes, Rennes, France (Batail, Le Jeune, Sauleau, S. Drapier, Vérin, D. Drapier, Robert); Eugène Marquis Centre, Rennes, France (Le Jeune); Neurophysiology Department, Rennes University Hospital, Rennes, France (Sauleau); Movement Disorders Unit, Rennes University Hospital, Rennes, France (S. Drapier, Vérin); Psychiatry Department, Pitié-Salpêtrière Hospital, Paris, France (Millet); University of Louvain-la-Neuve, Louvain-la-Neuve, Belgium (Philippot)
| | - Paul Sauleau
- From the University Department of Psychiatry, Guillaume Régnier Hospital, Rennes, France (Batail, D. Drapier, Robert); University of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France (Dondaine); Behaviour and Basal Ganglia Laboratory (EA 4712), University of Rennes, Rennes, France (Batail, Le Jeune, Sauleau, S. Drapier, Vérin, D. Drapier, Robert); Eugène Marquis Centre, Rennes, France (Le Jeune); Neurophysiology Department, Rennes University Hospital, Rennes, France (Sauleau); Movement Disorders Unit, Rennes University Hospital, Rennes, France (S. Drapier, Vérin); Psychiatry Department, Pitié-Salpêtrière Hospital, Paris, France (Millet); University of Louvain-la-Neuve, Louvain-la-Neuve, Belgium (Philippot)
| | - Sophie Drapier
- From the University Department of Psychiatry, Guillaume Régnier Hospital, Rennes, France (Batail, D. Drapier, Robert); University of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France (Dondaine); Behaviour and Basal Ganglia Laboratory (EA 4712), University of Rennes, Rennes, France (Batail, Le Jeune, Sauleau, S. Drapier, Vérin, D. Drapier, Robert); Eugène Marquis Centre, Rennes, France (Le Jeune); Neurophysiology Department, Rennes University Hospital, Rennes, France (Sauleau); Movement Disorders Unit, Rennes University Hospital, Rennes, France (S. Drapier, Vérin); Psychiatry Department, Pitié-Salpêtrière Hospital, Paris, France (Millet); University of Louvain-la-Neuve, Louvain-la-Neuve, Belgium (Philippot)
| | - Marc Vérin
- From the University Department of Psychiatry, Guillaume Régnier Hospital, Rennes, France (Batail, D. Drapier, Robert); University of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France (Dondaine); Behaviour and Basal Ganglia Laboratory (EA 4712), University of Rennes, Rennes, France (Batail, Le Jeune, Sauleau, S. Drapier, Vérin, D. Drapier, Robert); Eugène Marquis Centre, Rennes, France (Le Jeune); Neurophysiology Department, Rennes University Hospital, Rennes, France (Sauleau); Movement Disorders Unit, Rennes University Hospital, Rennes, France (S. Drapier, Vérin); Psychiatry Department, Pitié-Salpêtrière Hospital, Paris, France (Millet); University of Louvain-la-Neuve, Louvain-la-Neuve, Belgium (Philippot)
| | - Bruno Millet
- From the University Department of Psychiatry, Guillaume Régnier Hospital, Rennes, France (Batail, D. Drapier, Robert); University of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France (Dondaine); Behaviour and Basal Ganglia Laboratory (EA 4712), University of Rennes, Rennes, France (Batail, Le Jeune, Sauleau, S. Drapier, Vérin, D. Drapier, Robert); Eugène Marquis Centre, Rennes, France (Le Jeune); Neurophysiology Department, Rennes University Hospital, Rennes, France (Sauleau); Movement Disorders Unit, Rennes University Hospital, Rennes, France (S. Drapier, Vérin); Psychiatry Department, Pitié-Salpêtrière Hospital, Paris, France (Millet); University of Louvain-la-Neuve, Louvain-la-Neuve, Belgium (Philippot)
| | - Dominique Drapier
- From the University Department of Psychiatry, Guillaume Régnier Hospital, Rennes, France (Batail, D. Drapier, Robert); University of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France (Dondaine); Behaviour and Basal Ganglia Laboratory (EA 4712), University of Rennes, Rennes, France (Batail, Le Jeune, Sauleau, S. Drapier, Vérin, D. Drapier, Robert); Eugène Marquis Centre, Rennes, France (Le Jeune); Neurophysiology Department, Rennes University Hospital, Rennes, France (Sauleau); Movement Disorders Unit, Rennes University Hospital, Rennes, France (S. Drapier, Vérin); Psychiatry Department, Pitié-Salpêtrière Hospital, Paris, France (Millet); University of Louvain-la-Neuve, Louvain-la-Neuve, Belgium (Philippot)
| | - Gabriel Robert
- From the University Department of Psychiatry, Guillaume Régnier Hospital, Rennes, France (Batail, D. Drapier, Robert); University of Lille, Inserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, F-59000, Lille, France (Dondaine); Behaviour and Basal Ganglia Laboratory (EA 4712), University of Rennes, Rennes, France (Batail, Le Jeune, Sauleau, S. Drapier, Vérin, D. Drapier, Robert); Eugène Marquis Centre, Rennes, France (Le Jeune); Neurophysiology Department, Rennes University Hospital, Rennes, France (Sauleau); Movement Disorders Unit, Rennes University Hospital, Rennes, France (S. Drapier, Vérin); Psychiatry Department, Pitié-Salpêtrière Hospital, Paris, France (Millet); University of Louvain-la-Neuve, Louvain-la-Neuve, Belgium (Philippot)
| |
Collapse
|
21
|
Zietemann V, Georgakis MK, Dondaine T, Müller C, Mendyk AM, Kopczak A, Hénon H, Bombois S, Wollenweber FA, Bordet R, Dichgans M. Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke. Neurology 2018; 91:e1838-e1850. [PMID: 30333158 DOI: 10.1212/wnl.0000000000006506] [Citation(s) in RCA: 88] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Accepted: 08/01/2018] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To examine whether the Montreal Cognitive Assessment (MoCA) administered within 7 days after stroke predicts long-term cognitive impairment, functional impairment, and mortality. METHODS MoCA was administered to 274 patients from 2 prospective hospital-based cohort studies in Germany (n = 125) and France (n = 149). Cognitive and functional outcomes were assessed at 6, 12, and 36 months after stroke by comprehensive neuropsychological testing, the Clinical Dementia Rating (CDR) scale, the modified Rankin Scale (mRS), and Instrumental Activities of Daily Living (IADL) and analyzed with generalized estimating equations. All-cause mortality was investigated by Cox proportional hazard models. Analyses were adjusted for demographic variables, education, vascular risk factors, premorbid cognitive status, and NIH Stroke Scale scores. The additive predictive value of MoCA was examined with receiver operating characteristic curves. RESULTS In pooled analyses, a baseline MoCA score <26 was associated with cognitive impairment, defined by neuropsychological testing (odds ratio [OR] 5.30, 95% confidence interval [CI] 2.75-10.22) and by CDR score ≥0.5 (OR 2.53, 95% CI 1.53-4.18); functional impairment, defined by mRS score >2 (OR 5.03, 95% CI 2.20-11.51) and by IADL score <8 (OR 2.48, 95% CI 1.40-4.38); and mortality (hazard ratio 7.24, 95% CI 1.99-26.35) across the 3-year follow-up. Patients with MoCA score <26 performed worse across all prespecified cognitive domains (executive function/attention, memory, language, visuospatial ability). MoCA increased the area under the curve for predicting cognitive impairment (neuropsychological testing 0.81 vs 0.72, p = 0.01) and functional impairment (mRS score >2, 0.88 vs 0.84, p = 0.047). CONCLUSION Early cognitive testing by MoCA predicts long-term cognitive outcome, functional outcome, and mortality after stroke. Our results support routine use of the MoCA in stroke patients.
Collapse
Affiliation(s)
- Vera Zietemann
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany
| | - Marios K Georgakis
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany
| | - Thibaut Dondaine
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany
| | - Claudia Müller
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany
| | - Anne-Marie Mendyk
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany
| | - Anna Kopczak
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany
| | - Hilde Hénon
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany
| | - Stéphanie Bombois
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany
| | - Frank Arne Wollenweber
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany
| | - Régis Bordet
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany
| | - Martin Dichgans
- From the Institute for Stroke and Dementia Research (V.Z., M.K.G., C.M., A.K., F.A.W., M.D.), University Hospital, Ludwig-Maximilians-University, Munich, Germany; University of Lille (T.D., A.-M.M., H.H., S.B., R.B.), Inserm, CHU Lille, "Degenerative and Vascular Cognitive Disorders", Lille, France; German Centre for Neurodegenerative Diseases (M.D.); and Munich Cluster for Systems Neurology (M.D.), Germany.
| |
Collapse
|
22
|
Bournonville C, Hénon H, Dondaine T, Delmaire C, Bombois S, Mendyk AM, Cordonnier C, Moulin S, Leclerc X, Bordet R, Lopes R. Identification of a specific functional network altered in poststroke cognitive impairment. Neurology 2018; 90:e1879-e1888. [DOI: 10.1212/wnl.0000000000005553] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2017] [Accepted: 03/02/2018] [Indexed: 12/22/2022] Open
Abstract
ObjectiveTo study the association between poststroke cognitive impairment and defining a specific resting functional marker.MethodsThe resting-state functional connectivity 6 months after an ischemic stroke in 56 patients was investigated. Twenty-nine of the patients who had an impairment of one or several cognitive domains were compared to 27 without any cognitive deficit. We studied the whole-brain connectivity using 2 complementary approaches: graph theory to study the functional network organization and network-based statistics to explore connectivity between brain regions. We assessed the potential cortical atrophy using voxel-based morphometry analysis.ResultsThe overall topological organization of the functional network was not altered in cognitively impaired stroke patients, who had the same mean node degree, average clustering coefficient, and global efficiency as cognitively healthy stroke patients. Network-based statistics analysis showed that poststroke cognitive impairment was associated with dysfunction of a whole-brain network composed of 167 regions and 178 connections, and functional disconnections between superior, middle, and inferior frontal gyri and the superior and inferior temporal gyri. These regions had connections that were specifically and positively correlated with cognitive domain scores. No intergroup differences in overall gray matter thickness and ischemic infarct topography were observed. To assess the effect of prestroke white matter hyperintensities on connectivity, we included the initial Fazekas scale in the regression model for a second network-based analysis. The resulting network was associated with the same key alterations but had fewer connections.ConclusionsThe observed functional network alterations suggest that the appearance of a cognitive impairment following stroke may be associated with a particular functional alteration, shared specifically between cognitive domains.
Collapse
|
23
|
Péron J, Renaud O, Haegelen C, Tamarit L, Milesi V, Houvenaghel JF, Dondaine T, Vérin M, Sauleau P, Grandjean D. Vocal emotion decoding in the subthalamic nucleus: An intracranial ERP study in Parkinson's disease. Brain Lang 2017; 168:1-11. [PMID: 28088666 DOI: 10.1016/j.bandl.2016.12.003] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/27/2016] [Revised: 11/22/2016] [Accepted: 12/12/2016] [Indexed: 05/13/2023]
Abstract
Using intracranial local field potential (LFP) recordings in patients with Parkinson's disease (PD) undergoing deep brain stimulation (DBS), we explored the electrophysiological activity of the subthalamic nucleus (STN) in response to emotional stimuli in the auditory modality. Previous studies focused on the influence of visual stimuli. To this end, we recorded LFPs within the STN in response to angry, happy, and neutral prosodies in 13 patients with PD who had just undergone implantation of DBS electrodes. We observed specific modulation of the right STN in response to anger and happiness, as opposed to neutral prosody, occurring at around 200-300ms post-onset, and later at around 850-950ms post-onset for anger and at around 3250-3350ms post-onset for happiness. Taken together with previous reports of modulated STN activity in response to emotional visual stimuli, the present results appear to confirm that the STN is involved in emotion processing irrespective of stimulus valence and sensory modality.
Collapse
Affiliation(s)
- Julie Péron
- 'Neuroscience of Emotion and Affective Dynamics' Laboratory, Department of Psychology & Swiss Center for Affective Sciences, University of Geneva, 40 bd du Pont d'Arve, 1205 Geneva, Switzerland; Neuropsychology Unit, Department of Neurology, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland.
| | - Olivier Renaud
- Methodology and Data Analysis Unit, Department of Psychology, University of Geneva, 40 bd du Pont d'Arve, 1205 Geneva, Switzerland
| | - Claire Haegelen
- Neurosurgery Department, Pontchaillou Hospital, Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France; INSERM, LTSI U1099, Faculty of Medicine, CS 34317, University of Rennes I, F-35042 Rennes, France
| | - Lucas Tamarit
- Neuropsychology Unit, Department of Neurology, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland
| | - Valérie Milesi
- 'Neuroscience of Emotion and Affective Dynamics' Laboratory, Department of Psychology & Swiss Center for Affective Sciences, University of Geneva, 40 bd du Pont d'Arve, 1205 Geneva, Switzerland; Neuropsychology Unit, Department of Neurology, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland
| | - Jean-François Houvenaghel
- 'Behavior and Basal Ganglia' Research Unit (EA 4712), University of Rennes 1, Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France; Neurology Department, Pontchaillou Hospital, Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France
| | - Thibaut Dondaine
- 'Behavior and Basal Ganglia' Research Unit (EA 4712), University of Rennes 1, Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France; Neurology Department, Pontchaillou Hospital, Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France; Adult Psychiatry Department, Guillaume Régnier Hospital, 108 avenue du Général Leclerc, 35703 Rennes, France
| | - Marc Vérin
- 'Behavior and Basal Ganglia' Research Unit (EA 4712), University of Rennes 1, Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France; Neurology Department, Pontchaillou Hospital, Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France
| | - Paul Sauleau
- 'Behavior and Basal Ganglia' Research Unit (EA 4712), University of Rennes 1, Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France; Physiology Department, Pontchaillou Hospital, Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France
| | - Didier Grandjean
- 'Neuroscience of Emotion and Affective Dynamics' Laboratory, Department of Psychology & Swiss Center for Affective Sciences, University of Geneva, 40 bd du Pont d'Arve, 1205 Geneva, Switzerland; Neuropsychology Unit, Department of Neurology, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland
| |
Collapse
|
24
|
Duprez J, Houvenaghel JF, Argaud S, Naudet F, Dondaine T, Auffret M, Robert G, Drapier D, Vérin M, Sauleau P. Enhanced Impulsive Action Selection in Middle-Aged Adults-Insights From an Oculomotor Simon Task. Front Aging Neurosci 2016; 8:251. [PMID: 27826239 PMCID: PMC5078725 DOI: 10.3389/fnagi.2016.00251] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2016] [Accepted: 10/13/2016] [Indexed: 11/17/2022] Open
Abstract
Several studies have investigated the age-related impact in cognitive action control. However, to our knowledge, none of the studies have focused on the effect of moderate age on the strength of automatic activation according to the activation-suppression model. We therefore investigated the effect of moderate age on cognitive action control using an oculomotor version of the Simon task and distributional analyses. A group of middle-aged (n = 39; 57 ± 9 years) healthy adults were compared to a group of young healthy participants (n = 43; 24 ± 3 years). We first analyzed the overall impact of age on the congruence effect and then used conditional accuracy functions (CAFs) and delta plots to assess the strength of automatic activation and selective inhibition, respectively. Compared to young participants, middle-aged participants showed a greater congruence effect as well as higher rates of fast errors in conflict situations indicating an enhanced impulsive action selection. Furthermore, the overall downward slope of the congruence effect’s evolution was significantly steeper in older participants and the last slope tended to be significantly steeper. This may indicate that the middle-aged participants exerted a stronger selective inhibition. Our results suggest that middle-aged adults are more prone to impulsive action selection than young adults. Recent theories postulate that older adults might implement compensatory mechanisms to supply cognitive difficulties. This is in line with our results suggesting a potential greater selective inhibition. Overall, this study proposes that moderate aging impacts both processes of impulsive response selection and suppression underlying cognitive action control.
Collapse
Affiliation(s)
- Joan Duprez
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1 Rennes, France
| | - Jean-François Houvenaghel
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Neurology Department, Rennes University HospitalRennes, France
| | - Soizic Argaud
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Neuroscience of Emotion and Affective Dynamics Laboratory, Swiss Center for Affective SciencesGeneva, Switzerland
| | - Florian Naudet
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Adult Psychiatry Department, Rennes University HospitalRennes, France; Clinical Investigation Center (INSERM 0203), Department of Pharmacology, Rennes University HospitalRennes, France
| | - Thibaut Dondaine
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Adult Psychiatry Department, Rennes University HospitalRennes, France
| | - Manon Auffret
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1 Rennes, France
| | - Gabriel Robert
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Adult Psychiatry Department, Rennes University HospitalRennes, France
| | - Dominique Drapier
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Adult Psychiatry Department, Rennes University HospitalRennes, France
| | - Marc Vérin
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Neurology Department, Rennes University HospitalRennes, France
| | - Paul Sauleau
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Neurophysiology Department, Rennes University HospitalRennes, France
| |
Collapse
|
25
|
Houvenaghel JF, Duprez J, Argaud S, Naudet F, Dondaine T, Robert GH, Drapier S, Haegelen C, Jannin P, Drapier D, Vérin M, Sauleau P. Influence of subthalamic deep-brain stimulation on cognitive action control in incentive context. Neuropsychologia 2016; 91:519-530. [PMID: 27664297 DOI: 10.1016/j.neuropsychologia.2016.09.015] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2016] [Revised: 08/23/2016] [Accepted: 09/20/2016] [Indexed: 01/24/2023]
Abstract
Subthalamic nucleus deep-brain stimulation (STN-DBS) is an effective treatment in Parkinson's disease (PD), but can have cognitive side effects, such as increasing the difficulty of producing appropriate responses when a habitual but inappropriate responses represent strong alternatives. STN-DBS also appears to modulate representations of incentives such as monetary rewards. Furthermore, conflict resolution can be modulated by incentive context. We therefore used a rewarded Simon Task to assess the influence of promised rewards on cognitive action control in 50 patients with PD, half of whom were being treated with STN-DBS. Results were analyzed according to the activation-suppression model. We showed that STN-DBS (i) favored the expression of motor impulsivity, as measured with the Barratt Impulsiveness Scale, (ii) facilitated the expression of incentive actions as observed with a greater increase in speed according to promised reward in patients with versus without DBS and (iii) may increase impulsive action selection in an incentive context. In addition, analysis of subgroups of implanted patients suggested that those who exhibited the most impulsive action selection had the least severe disease. This may indicate that patients with less marked disease are more at risk of developing impulsivity postoperatively. Finally, in these patients, incentive context increased the difficulty of resolving conflict situations. As a whole, the current study revealed that in patients with PD, STN-DBS affects the cognitive processes involved in conflict resolution, reward processing and the influence of promised rewards on conflict resolution.
Collapse
Affiliation(s)
- Jean-François Houvenaghel
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Neurology, Rennes University Hospital, Rennes, France.
| | - Joan Duprez
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France
| | - Soizic Argaud
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France; "Neuroscience of Emotion and Affective Dynamics" Laboratory, Department of Psychology and Educational Sciences/Swiss Center for Affective Sciences, Campus Biotech, University of Geneva, Geneva, Switzerland
| | - Florian Naudet
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France; Clinical Investigation Center (INSERM 0203), Department of Pharmacology, Rennes University Hospital, Rennes, France; Department of Psychiatry, Rennes University Hospital, Rennes, France
| | - Thibaut Dondaine
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France
| | - Gabriel Hadrien Robert
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Psychiatry, Rennes University Hospital, Rennes, France
| | - Sophie Drapier
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Neurology, Rennes University Hospital, Rennes, France
| | - Claire Haegelen
- Department of Neurosurgery, Rennes University Hospital, Rennes, France; "MediCIS" laboratory (UMR 1099 LTSI), INSERM/University of Rennes, Rennes, France
| | - Pierre Jannin
- "MediCIS" laboratory (UMR 1099 LTSI), INSERM/University of Rennes, Rennes, France
| | - Dominique Drapier
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Psychiatry, Rennes University Hospital, Rennes, France
| | - Marc Vérin
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Neurology, Rennes University Hospital, Rennes, France
| | - Paul Sauleau
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Neurophysiology, Rennes University Hospital, Rennes, France
| |
Collapse
|
26
|
Houvenaghel JF, Duprez J, Naudet F, Argaud S, Dondaine T, Drapier S, Robert GH, Drapier D, Vérin M, Sauleau P. Influence of promised rewards on conflict resolution in healthy participants and patients with Parkinson's disease. J Neurol Sci 2016; 367:38-45. [PMID: 27423562 DOI: 10.1016/j.jns.2016.05.045] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2016] [Revised: 04/21/2016] [Accepted: 05/23/2016] [Indexed: 11/15/2022]
Affiliation(s)
- Jean-François Houvenaghel
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, F-35033 Rennes, France; Department of Neurology, Rennes University Hospital, F-35033 Rennes, France.
| | - Joan Duprez
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, F-35033 Rennes, France
| | - Florian Naudet
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, F-35033 Rennes, France; Clinical Investigation Center (INSERM 0203), Department of Pharmacology, Rennes University Hospital, F-35033 Rennes, France; Department of Adult Psychiatry, Rennes University Hospital, F-35033 Rennes, France
| | - Soizic Argaud
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, F-35033 Rennes, France; "Neuroscience of Emotion and Affective Dynamics" Laboratory, Department of Psychology and Educational Sciences, 40 boulevard du Pont d'Arve, 1205 Geneva, University of Geneva, Switzerland
| | - Thibaut Dondaine
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, F-35033 Rennes, France; Department of Neurology, Rennes University Hospital, F-35033 Rennes, France
| | - Sophie Drapier
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, F-35033 Rennes, France; Department of Neurology, Rennes University Hospital, F-35033 Rennes, France
| | - Gabriel Hadrien Robert
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, F-35033 Rennes, France; Department of Adult Psychiatry, Rennes University Hospital, F-35033 Rennes, France
| | - Dominique Drapier
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, F-35033 Rennes, France; Department of Adult Psychiatry, Rennes University Hospital, F-35033 Rennes, France
| | - Marc Vérin
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, F-35033 Rennes, France; Department of Neurology, Rennes University Hospital, F-35033 Rennes, France
| | - Paul Sauleau
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, F-35033 Rennes, France; Department of Neurophysiology, Rennes University Hospital, F-35033 Rennes, France
| |
Collapse
|
27
|
Sauleau P, Drapier S, Duprez J, Houvenaghel JF, Dondaine T, Haegelen C, Drapier D, Jannin P, Robert G, Le Jeune F, Vérin M. Weight Gain following Pallidal Deep Brain Stimulation: A PET Study. PLoS One 2016; 11:e0153438. [PMID: 27070317 PMCID: PMC4829218 DOI: 10.1371/journal.pone.0153438] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2015] [Accepted: 03/29/2016] [Indexed: 12/18/2022] Open
Abstract
The mechanisms behind weight gain following deep brain stimulation (DBS) surgery seem to be multifactorial and suspected depending on the target, either the subthalamic nucleus (STN) or the globus pallidus internus (GPi). Decreased energy expenditure following motor improvement and behavioral and/or metabolic changes are possible explanations. Focusing on GPi target, our objective was to analyze correlations between changes in brain metabolism (measured with PET) and weight gain following GPi-DBS in patients with Parkinson's disease (PD). Body mass index was calculated and brain activity prospectively measured using 2-deoxy-2[18F]fluoro-D-glucose PET four months before and four months after the start of GPi-DBS in 19 PD patients. Dopaminergic medication was included in the analysis to control for its possible influence on brain metabolism. Body mass index increased significantly by 0.66 ± 1.3 kg/m2 (p = 0.040). There were correlations between weight gain and changes in brain metabolism in premotor areas, including the left and right superior gyri (Brodmann area, BA 6), left superior gyrus (BA 8), the dorsolateral prefrontal cortex (right middle gyrus, BAs 9 and 46), and the left and right somatosensory association cortices (BA 7). However, we found no correlation between weight gain and metabolic changes in limbic and associative areas. Additionally, there was a trend toward a correlation between reduced dyskinesia and weight gain (r = 0.428, p = 0.067). These findings suggest that, unlike STN-DBS, motor improvement is the major contributing factor for weight gain following GPi-DBS PD, confirming the motor selectivity of this target.
Collapse
Affiliation(s)
- Paul Sauleau
- “Behavior and Basal Ganglia” research unit (EA 4712), University of Rennes 1, Avenue Léon Bernard, Rennes, France
- Department of Neurophysiology, Rennes University Hospital, rue Henri Le Guilloux, Rennes, France
- * E-mail:
| | - Sophie Drapier
- “Behavior and Basal Ganglia” research unit (EA 4712), University of Rennes 1, Avenue Léon Bernard, Rennes, France
- Department of Neurology, Rennes University Hospital, rue Henri Le Guilloux, Rennes, France
| | - Joan Duprez
- “Behavior and Basal Ganglia” research unit (EA 4712), University of Rennes 1, Avenue Léon Bernard, Rennes, France
| | - Jean-François Houvenaghel
- “Behavior and Basal Ganglia” research unit (EA 4712), University of Rennes 1, Avenue Léon Bernard, Rennes, France
- Department of Neurology, Rennes University Hospital, rue Henri Le Guilloux, Rennes, France
| | - Thibaut Dondaine
- “Behavior and Basal Ganglia” research unit (EA 4712), University of Rennes 1, Avenue Léon Bernard, Rennes, France
| | - Claire Haegelen
- Department of Neurosurgery, Rennes University Hospital, rue Henri Le Guilloux, Rennes, France
- “MediCIS” laboratory (UMR 1099 LTSI), INSERM, University of Rennes 1, Avenue Léon Bernard, Rennes, France
| | - Dominique Drapier
- “Behavior and Basal Ganglia” research unit (EA 4712), University of Rennes 1, Avenue Léon Bernard, Rennes, France
- Department of Psychiatry, Rennes University Hospital, avenue du Général Leclerc, Rennes, France
| | - Pierre Jannin
- Department of Neurosurgery, Rennes University Hospital, rue Henri Le Guilloux, Rennes, France
| | - Gabriel Robert
- “Behavior and Basal Ganglia” research unit (EA 4712), University of Rennes 1, Avenue Léon Bernard, Rennes, France
- Department of Psychiatry, Rennes University Hospital, avenue du Général Leclerc, Rennes, France
| | - Florence Le Jeune
- “Behavior and Basal Ganglia” research unit (EA 4712), University of Rennes 1, Avenue Léon Bernard, Rennes, France
- Department of Oncology, Eugene Marquis Center, Avenue de la Bataille Flandres-Dunkerque, Rennes, France
| | - Marc Vérin
- “Behavior and Basal Ganglia” research unit (EA 4712), University of Rennes 1, Avenue Léon Bernard, Rennes, France
- Department of Neurology, Rennes University Hospital, rue Henri Le Guilloux, Rennes, France
| |
Collapse
|
28
|
Duprez J, Houvenaghel JF, Naudet F, Dondaine T, Auffret M, Robert G, Drapier D, Argaud S, Vérin M, Sauleau P. Evaluating Cognitive Action Control Using Eye-Movement Analysis: An Oculomotor Adaptation of the Simon Task. Front Hum Neurosci 2016; 10:84. [PMID: 26973499 PMCID: PMC4773592 DOI: 10.3389/fnhum.2016.00084] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2016] [Accepted: 02/18/2016] [Indexed: 11/25/2022] Open
Abstract
Cognitive action control has been extensively studied using conflict tasks such as the Simon task. In most recent studies, this process has been investigated in the light of the dual route hypothesis and more specifically of the activation-suppression model using distributional analyses. Some authors have suggested that cognitive action control assessment is not specific to response modes. In this study we adapted the Simon task, using oculomotor responses instead of manual responses, in order to evaluate whether the resolution of conflict induced by a two-dimensional stimulus yielded similar results to what is usually reported in tasks with manual responses. Results obtained from 43 young healthy participants revealed the typical congruence effect, with longer reaction times (RT) and lesser accuracy in the incongruent condition. Conditional accuracy functions (CAF) also revealed a higher proportion of fast errors in the incongruent condition and delta plots confirmed that conflict resolution was easier, as the time taken to respond increased. These results are very similar to what has been reported in the literature. Furthermore, our observations are in line with the assumptions of the activation-suppression model, in which automatic activation in conflict situations is captured in the fastest responses and selective inhibition of cognitive action control needs time to build up. Altogether, our results suggest that conflict resolution has core mechanisms whatever the response mode, manual or oculomotor. Using oculomotor responses in such tasks could be of interest when investigating cognitive action control in patients with severe motor disorders.
Collapse
Affiliation(s)
- Joan Duprez
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1 Rennes, France
| | - Jean-François Houvenaghel
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Neurology Department, Rennes University HospitalRennes, France
| | - Florian Naudet
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Adult Psychiatry Department, Rennes University HospitalRennes, France; Clinical Investigation Center (INSERM 0203), Department of Pharmacology, Rennes University HospitalRennes, France
| | - Thibaut Dondaine
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Adult Psychiatry Department, Rennes University HospitalRennes, France
| | - Manon Auffret
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1 Rennes, France
| | - Gabriel Robert
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Adult Psychiatry Department, Rennes University HospitalRennes, France
| | - Dominique Drapier
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Adult Psychiatry Department, Rennes University HospitalRennes, France
| | - Soizic Argaud
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Neuroscience of Emotion and Affective Dynamics Lab, Swiss Center for Affective SciencesGeneva, Switzerland
| | - Marc Vérin
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Neurology Department, Rennes University HospitalRennes, France
| | - Paul Sauleau
- "Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1Rennes, France; Neurophysiology Department, Rennes University HospitalRennes, France
| |
Collapse
|
29
|
Dondaine T, Douailler-Gautier B, Guillery M, Robert G, Millet B, Guillaume S, Drapier D. Recognition Of Emotional Prosody In Anorexia Nervosa. Eur Psychiatry 2016. [DOI: 10.1016/j.eurpsy.2016.01.1546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Abstract
Deficits in emotional processes are often observed by clinicians in anorexia nervosa and may have an impact on social functioning. Recognition of emotion was mostly investigated using visual stimuli as faces of emotional scenes. Only one study (Kucharska-Pietura et al., 2004) demonstrated impairments in emotional prosody using positive and negative valenced stimuli. However, this study did not provide a highlight for the identification of emotional bias (for example, to recognize an intense fear in a friendly voice). The aim of this study is to better understand the recognition of emotional prosody in anorexia nervosa using a wide range of positive, negative and neutral stimuli (Belin et al., 2008).In order to test emotion recognition biases in emotional prosody, we exposed 15 patients with anorexia nervosa and 15 healthy controls (HCs) to emotional vocal tasks asking them to rate emotional intensity on visual analog scales. In addition, we assessed clinical symptomatology and cognitive functioning for all participants.We showed that patients with anorexia nervosa provided higher intensity ratings on the non-target scales (e.g., surprise scale for fear stimuli) than HCs for sadness, fear and neutral voices. Furthermore, with the exception of neutral vocal stimuli, they provided the same intensity ratings on the target scales as the HCs.These findings suggested a bias in the processing of emotional prosody and may impact the social functioning of patients with anorexia nervosa. The bias may result from a sensorial deficit or a high-order cognitive dysfunction and have to be investigated in future studies.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Collapse
|
30
|
Choppin S, Trost W, Dondaine T, Millet B, Drapier D, Vérin M, Robert G, Grandjean D. Alteration of complex negative emotions induced by music in euthymic patients with bipolar disorder. J Affect Disord 2016; 191:15-23. [PMID: 26605497 DOI: 10.1016/j.jad.2015.10.063] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2015] [Revised: 09/23/2015] [Accepted: 10/23/2015] [Indexed: 11/25/2022]
Abstract
BACKGROUND Research has shown bipolar disorder to be characterized by dysregulation of emotion processing, including biases in facial expression recognition that is most prevalent during depressive and manic states. Very few studies have examined induced emotions when patients are in a euthymic phase, and there has been no research on complex emotions. We therefore set out to test emotional hyperreactivity in response to musical excerpts inducing complex emotions in bipolar disorder during euthymia. METHODS We recruited 21 patients with bipolar disorder (BD) in a euthymic phase and 21 matched healthy controls. Participants first rated their emotional reactivity on two validated self-report scales (ERS and MAThyS). They then rated their music-induced emotions on nine continuous scales. The targeted emotions were wonder, power, melancholy and tension. We used a specific generalized linear mixed model to analyze the behavioral data. RESULTS We found that participants in the euthymic bipolar group experienced more intense complex negative emotions than controls when the musical excerpts induced wonder. Moreover, patients exhibited greater emotional reactivity in daily life (ERS). Finally, a greater experience of tension while listening to positive music seemed to be mediated by greater emotional reactivity and a deficit in executive functions. LIMITATIONS The heterogeneity of the BD group in terms of clinical characteristics may have influenced the results. CONCLUSIONS Euthymic patients with bipolar disorder exhibit more complex negative emotions than controls in response to positive music.
Collapse
Affiliation(s)
- Sabine Choppin
- 'Behavior and Basal Ganglia' laboratory (EA 4712), University of Rennes 1, Rennes, France; Psychiatry Unit, Guillaume Régnier Hospital, Rennes, France.
| | - Wiebke Trost
- 'Neuroscience of Emotion and Affective Dynamics' laboratory, Department of Psychology, University of Geneva, Switzerland; Swiss Center for Affective Sciences, University of Geneva, Switzerland.
| | - Thibaut Dondaine
- 'Behavior and Basal Ganglia' laboratory (EA 4712), University of Rennes 1, Rennes, France; Psychiatry Unit, Guillaume Régnier Hospital, Rennes, France
| | - Bruno Millet
- 'Behavior and Basal Ganglia' laboratory (EA 4712), University of Rennes 1, Rennes, France; Psychiatry Unit, Guillaume Régnier Hospital, Rennes, France
| | - Dominique Drapier
- 'Behavior and Basal Ganglia' laboratory (EA 4712), University of Rennes 1, Rennes, France; Psychiatry Unit, Guillaume Régnier Hospital, Rennes, France
| | - Marc Vérin
- 'Behavior and Basal Ganglia' laboratory (EA 4712), University of Rennes 1, Rennes, France; Neurology Unit, Rennes University Hospital, Rennes, France
| | - Gabriel Robert
- 'Behavior and Basal Ganglia' laboratory (EA 4712), University of Rennes 1, Rennes, France; Psychiatry Unit, Guillaume Régnier Hospital, Rennes, France
| | - Didier Grandjean
- 'Neuroscience of Emotion and Affective Dynamics' laboratory, Department of Psychology, University of Geneva, Switzerland; Swiss Center for Affective Sciences, University of Geneva, Switzerland
| |
Collapse
|
31
|
Ory S, Le Jeune F, Haegelen C, Vicente S, Philippot P, Dondaine T, Jannin P, Drapier S, Drapier D, Sauleau P, Vérin M, Péron J. Pre-frontal-insular-cerebellar modifications correlate with disgust feeling blunting after subthalamic stimulation: A positron emission tomography study in Parkinson's disease. J Neuropsychol 2015; 11:378-395. [PMID: 26670087 DOI: 10.1111/jnp.12094] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2015] [Revised: 10/26/2015] [Indexed: 12/01/2022]
Abstract
Subthalamic nucleus (STN) deep brain stimulation (DBS) has recently advanced our understanding of the major role played by this basal ganglion in human emotion. Research indicates that STN DBS can induce modifications in all components of emotion, and neuroimaging studies have shown that the metabolic modifications correlated with these emotional disturbances following surgery are both task- and sensory input-dependent. Nevertheless, to date, these modifications have not been confirmed for all emotional components, notably subjective emotional experience, or feelings. To identify the neural network underlying the modification of feelings following STN DBS, we assessed 16 patients with Parkinson's disease before and after surgery, using both subjective assessments of emotional experience and 18 [F]fluorodeoxyglucose positron emission tomography (18 FDG-PET). The patients viewed six film excerpts intended to elicit happy, angry, fearful, sad, disgusted, and neutral feelings, and they self-rated the intensity of these feelings. After DBS, there was a significant reduction in the intensity of the disgust feeling. Correlations were observed between decreased disgust experience and cerebral glucose metabolism (FDG uptake) in the bilateral pre-frontal cortices (orbitofrontal, dorsolateral, and inferior frontal gyri), bilateral insula, and right cerebellum. We suggest that the STN contributes to the synchronization process underlying the emergence of feelings.
Collapse
Affiliation(s)
- Sophie Ory
- 'Behaviour and Basal Ganglia' Research Unit, University of Rennes 1, Rennes University Hospital, France.,Neurology Department, Rennes University Hospital, France
| | - Florence Le Jeune
- 'Behaviour and Basal Ganglia' Research Unit, University of Rennes 1, Rennes University Hospital, France.,Nuclear Medicine Department, Eugène Marquis Centre, Rennes, France
| | - Claire Haegelen
- MediCIS, INSERM, Faculty of Medicine, University of Rennes I, France.,Neurosurgery Department, Rennes University Hospital, France
| | - Siobhan Vicente
- UMR CNRS 7295, Centre for Research on Cognition and Learning, Poitiers, France
| | - Pierre Philippot
- Department of Psychology, University of Louvain-La-Neuve, Belgium
| | - Thibaut Dondaine
- 'Behaviour and Basal Ganglia' Research Unit, University of Rennes 1, Rennes University Hospital, France
| | - Pierre Jannin
- MediCIS, INSERM, Faculty of Medicine, University of Rennes I, France
| | - Sophie Drapier
- 'Behaviour and Basal Ganglia' Research Unit, University of Rennes 1, Rennes University Hospital, France.,Neurology Department, Rennes University Hospital, France
| | - Dominique Drapier
- 'Behaviour and Basal Ganglia' Research Unit, University of Rennes 1, Rennes University Hospital, France.,Adult Psychiatry Department, Guillaume Régnier Hospital, Rennes, France
| | - Paul Sauleau
- 'Behaviour and Basal Ganglia' Research Unit, University of Rennes 1, Rennes University Hospital, France.,Physiology Department, Rennes University Hospital, France
| | - Marc Vérin
- 'Behaviour and Basal Ganglia' Research Unit, University of Rennes 1, Rennes University Hospital, France.,Neurology Department, Rennes University Hospital, France
| | - Julie Péron
- 'Neuroscience of Emotion and Affective Dynamics' Laboratory, Department of Psychology and Swiss Centre for Affective Sciences, University of Geneva, Switzerland
| |
Collapse
|
32
|
Dondaine T, Douailler-Gautier B, Guillery M, Robert G, Millet B, Guillaume S, Drapier D. Recognition of emotional prosody in anorexia nervosa. Eur Psychiatry 2015. [DOI: 10.1016/j.eurpsy.2015.09.218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Deficits in emotional processes are often observed by clinicians in anorexia nervosa and may have an impact on social functioning. Recognition of emotion was mostly investigated using visual stimuli as faces of emotional scenes. Only one study (Kucharska-Pietura et al., 2004) demonstrated impairments in emotional prosody using positive and negative valenced stimuli. However, this study did not provide a highlight for the identification of emotional bias (for example, to recognize an intense fear in a friendly voice). The aim of this study is to better understand the recognition of emotional prosody in anorexia nervosa using a wide range of positive, negative and neutral stimuli (Belin et al., 2008). In order to test emotion recognition biases in emotional prosody, we exposed 15 patients with anorexia nervosa and 15 healthy controls (HCs) to emotional vocal tasks asking them to rate emotional intensity on visual analog scales. In addition, we assessed clinical symptomatology and cognitive functioning for all participants. We showed that patients with anorexia nervosa provided higher intensity ratings on the non-target scales (e.g., surprise scale for fear stimuli) than HCs for sadness, fear and neutral voices. Furthermore, with the exception of neutral vocal stimuli, they provided the same intensity ratings on the target scales as the HCs. These findings suggested a bias in the processing of emotional prosody and may impact the social functioning of patients with anorexia nervosa. The bias may result from a sensorial deficit or a high-order cognitive dysfunction and have to be investigated in future studies.
Collapse
|
33
|
Houvenaghel JF, Le Jeune F, Dondaine T, Esquevin A, Robert GH, Péron J, Haegelen C, Drapier S, Jannin P, Lozachmeur C, Argaud S, Duprez J, Drapier D, Vérin M, Sauleau P. Reduced Verbal Fluency following Subthalamic Deep Brain Stimulation: A Frontal-Related Cognitive Deficit? PLoS One 2015; 10:e0140083. [PMID: 26448131 PMCID: PMC4598145 DOI: 10.1371/journal.pone.0140083] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2015] [Accepted: 09/21/2015] [Indexed: 11/19/2022] Open
Abstract
Objective The decrease in verbal fluency in patients with Parkinson’s disease (PD) undergoing subthalamic nucleus deep brain stimulation (STN-DBS) is usually assumed to reflect a frontal lobe-related cognitive dysfunction, although evidence for this is lacking. Methods To explore its underlying mechanisms, we combined neuropsychological, psychiatric and motor assessments with an examination of brain metabolism using F-18 fluorodeoxyglucose positron emission tomography, in 26 patients with PD, 3 months before and after surgery. We divided these patients into two groups, depending on whether or not they exhibited a postoperative deterioration in either phonemic (10 patients) or semantic (8 patients) fluency. We then compared the STN-DBS groups with and without verbal deterioration on changes in clinical measures and brain metabolism. Results We did not find any neuropsychological change supporting the presence of an executive dysfunction in patients with a deficit in either phonemic or semantic fluency. Similarly, a comparison of patients with or without impaired fluency on brain metabolism failed to highlight any frontal areas involved in cognitive functions. However, greater changes in cognitive slowdown and apathy were observed in patients with a postoperative decrease in verbal fluency. Conclusions These results suggest that frontal lobe-related cognitive dysfunction could play only a minor role in the postoperative impairment of phonemic or semantic fluency, and that cognitive slowdown and apathy could have a more decisive influence. Furthermore, the phonemic and semantic impairments appeared to result from the disturbance of distinct mechanisms.
Collapse
Affiliation(s)
- Jean-François Houvenaghel
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
- Department of Neurology, Rennes University Hospital, Rennes, France
- * E-mail:
| | - Florence Le Jeune
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
- Department of Nuclear Medicine, Eugène Marquis Hospital, Rennes, France
| | - Thibaut Dondaine
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
| | - Aurore Esquevin
- Department of Neuroradiology, Rennes University Hospital, Rennes, France
| | - Gabriel Hadrien Robert
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
- Department of Psychiatry, Rennes University Hospital, Rennes, France
| | - Julie Péron
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
- ‘Neuroscience of Emotion and Affective Dynamics’ laboratory, Department of Psychology, and Swiss Center for Affective Sciences, University of Geneva, Geneva, Switzerland
| | - Claire Haegelen
- Department of Neurosurgery, Rennes University Hospital, Rennes, France
- “MediCIS” laboratory (UMR 1099 LTSI), Inserm/University of Rennes, Rennes, France
| | - Sophie Drapier
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
- Department of Neurology, Rennes University Hospital, Rennes, France
| | - Pierre Jannin
- “MediCIS” laboratory (UMR 1099 LTSI), Inserm/University of Rennes, Rennes, France
| | - Clément Lozachmeur
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
- Department of Psychiatry, Rennes University Hospital, Rennes, France
| | - Soizic Argaud
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
- ‘Neuroscience of Emotion and Affective Dynamics’ laboratory, Department of Psychology, and Swiss Center for Affective Sciences, University of Geneva, Geneva, Switzerland
| | - Joan Duprez
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
| | - Dominique Drapier
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
- Department of Psychiatry, Rennes University Hospital, Rennes, France
| | - Marc Vérin
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
- Department of Neurology, Rennes University Hospital, Rennes, France
| | - Paul Sauleau
- “Behaviour and Basal Ganglia” research unit (EA 4712), University of Rennes, Rennes, France
- Department of Neurophysiology, Rennes University Hospital, Rennes, France
| |
Collapse
|
34
|
Lozachmeur C, Drapier S, Robert G, Dondaine T, Laviolle B, Sauleau P, Peron J, Le Jeune F, Travers D, Millet B, Vérin M, Drapier D. Pallidal stimulation in Parkinson's disease does not induce apathy. J Neuropsychiatry Clin Neurosci 2015; 26:221-6. [PMID: 24921969 DOI: 10.1176/appi.neuropsych.13020032] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
BACKGROUND Whereas apathy is known as a common consequence of subthalamic nucleus deep brain stimulation in Parkinson's disease, few studies have investigated the psychiatric consequences of internal globus pallidus deep brain stimulation. METHOD Twenty consecutive parkinsonian patients who underwent bilateral pallidal stimulation were assessed 3 months prior to surgery (M‒3) and at both 3 (M3) and 6 months (M6) after surgery, using psychiatric, neuropsychological, and motor scales. Apathy, mood state, and anxiety state were scored using the Apathy Evaluation Scale, the Montgomery-Åsberg Depression Rating Scale, and the anxiety scale from the Association for Methodology and Documentation in Psychiatry, respectively. RESULTS The mean apathy score remained stable between the preoperative M‒3 assessment (37.2±6.2) and both the postoperative M3 (36.9±7.5) and M6 (37.2±5.0) assessments. The mean depression score did not differ between the M‒3 assessment and M3 and M6 assessments. There was no difference between the preoperative mean anxiety score and both the postoperative M3 and M6 scores. The mean score for the Mattis Dementia Rating Scale remained stable at each study visit. CONCLUSIONS The main result of this study is the absence of deterioration in psychiatric and cognitive scores 3 months and 6 months after pallidal stimulation.
Collapse
|
35
|
Sauleau P, Le Jeune F, Drapier S, Houvenaghel JF, Dondaine T, Haegelen C, Lalys F, Robert G, Drapier D, Vérin M. Weight gain following subthalamic nucleus deep brain stimulation: A PET study. Mov Disord 2014; 29:1781-7. [DOI: 10.1002/mds.26063] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2014] [Revised: 09/30/2014] [Accepted: 10/03/2014] [Indexed: 12/14/2022] Open
Affiliation(s)
- Paul Sauleau
- “Behavior and Basal Ganglia” research unit (EA 4712); University of Rennes 1; Rennes France
- Rennes University Hospital; Rennes France
| | - Florence Le Jeune
- “Behavior and Basal Ganglia” research unit (EA 4712); University of Rennes 1; Rennes France
- Eugene Marquis Center; Department of Oncology; Rennes France
| | - Sophie Drapier
- “Behavior and Basal Ganglia” research unit (EA 4712); University of Rennes 1; Rennes France
- Rennes University Hospital; Rennes France
| | - Jean-François Houvenaghel
- “Behavior and Basal Ganglia” research unit (EA 4712); University of Rennes 1; Rennes France
- Rennes University Hospital; Rennes France
| | - Thibaut Dondaine
- “Behavior and Basal Ganglia” research unit (EA 4712); University of Rennes 1; Rennes France
- Rennes University Hospital; Rennes France
| | - Claire Haegelen
- “MediCIS” Laboratory (UMR 1099 LTSI), INSERM; University of Rennes 1; Rennes France
- Rennes University Hospital; Rennes France
| | - Florent Lalys
- “MediCIS” Laboratory (UMR 1099 LTSI), INSERM; University of Rennes 1; Rennes France
| | - Gabriel Robert
- “Behavior and Basal Ganglia” research unit (EA 4712); University of Rennes 1; Rennes France
- Rennes University Hospital; Rennes France
| | - Dominique Drapier
- “Behavior and Basal Ganglia” research unit (EA 4712); University of Rennes 1; Rennes France
- Rennes University Hospital; Rennes France
| | - Marc Vérin
- “Behavior and Basal Ganglia” research unit (EA 4712); University of Rennes 1; Rennes France
- Rennes University Hospital; Rennes France
| |
Collapse
|
36
|
Robert GH, Le Jeune F, Lozachmeur C, Drapier S, Dondaine T, Péron J, Houvenaghel JF, Travers D, Sauleau P, Millet B, Vérin M, Drapier D. Preoperative factors of apathy in subthalamic stimulated Parkinson disease: a PET study. Neurology 2014; 83:1620-6. [PMID: 25253750 DOI: 10.1212/wnl.0000000000000941] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE The current literature provides discrepant results regarding preoperative sociodemographic and clinical factors, and no information about preoperative cerebral metabolic patterns associated with apathy after subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson disease. METHODS To resolve this issue, we set out to identify preoperative metabolic patterns and sociodemographic and clinical factors associated with increased apathy after STN-DBS. Forty-four patients with Parkinson disease were enrolled in this study. They all underwent STN-DBS. Metabolic activity was assessed with F-18 fluorodeoxyglucose PET 3 months before surgery. Apathy was assessed on the Apathy Evaluation Scale 3 months before and after STN-DBS. We controlled for preoperative age, levodopa therapy, and overall cognitive functions. RESULTS Increased apathy after STN-DBS was significantly associated with reduced preoperative metabolism within the right ventral striatum. None of the sociodemographic and clinical variables tested were associated with apathy after STN-DBS. CONCLUSIONS Preoperative PET, but not sociodemographic or clinical factors, is associated with apathy after STN-DBS.
Collapse
Affiliation(s)
- Gabriel H Robert
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland.
| | - Florence Le Jeune
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| | - Clement Lozachmeur
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| | - Sophie Drapier
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| | - Thibaut Dondaine
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| | - Julie Péron
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| | - Jean-Francois Houvenaghel
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| | - David Travers
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| | - Paul Sauleau
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| | - Bruno Millet
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| | - Marc Vérin
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| | - Dominique Drapier
- From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland
| |
Collapse
|
37
|
Nauczyciel C, Le Jeune F, Naudet F, Douabin S, Esquevin A, Vérin M, Dondaine T, Robert G, Drapier D, Millet B. Repetitive transcranial magnetic stimulation over the orbitofrontal cortex for obsessive-compulsive disorder: a double-blind, crossover study. Transl Psychiatry 2014; 4:e436. [PMID: 25203167 PMCID: PMC4203001 DOI: 10.1038/tp.2014.62] [Citation(s) in RCA: 87] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2013] [Revised: 04/23/2014] [Accepted: 05/22/2014] [Indexed: 11/09/2022] Open
Abstract
This pilot study was designed to assess the efficacy of low-frequency repetitive transcranial magnetic stimulation (rTMS) over the right orbitofrontal cortex (OFC) by means of a double-cone coil in patients suffering from obsessive-compulsive disorder. We hypothesized that low-frequency stimulation of the OFC would lead to a reduction in clinical symptoms, as measured on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). A randomized, double-blind, crossover design was implemented with two 1-week treatment periods (active stimulation versus sham stimulation) separated by a 1-month washout period. Concomitantly, a subgroup of patients underwent a positron emission tomography (PET) scan after each stimulation sequence. Statistical analyses compared the Y-BOCS scores at the end of each period. At day 7, we observed a significant decrease from baseline in the Y-BOCS scores, after both active (P<0.01) and sham stimulation (P=0.02). This decrease tended to be larger after active stimulation than after sham stimulation: -6 (-29, 0) points versus -2 (-20, 4) points (P=0.07). Active versus sham PET scan contrasts showed that stimulation was related to a bilateral decrease in the metabolism of the OFC. The OFC should definitely be regarded as a key neuroanatomical target for rTMS, as it is easier to reach than either the striatum or the subthalamic nucleus, structures favored in neurosurgical approaches.
Collapse
Affiliation(s)
- C Nauczyciel
- EA-4712 Behavior and Basal Ganglia Unit, Université de Rennes 1, Rennes, France,Centre Hospitalier Guillaume Régnier, Service Hospitalo-Universitaire de Psychiatrie, Rennes, France
| | - F Le Jeune
- EA-4712 Behavior and Basal Ganglia Unit, Université de Rennes 1, Rennes, France,Département de Médecine Nucléaire, Centre Eugène Marquis, Rennes, France
| | - F Naudet
- EA-4712 Behavior and Basal Ganglia Unit, Université de Rennes 1, Rennes, France,Centre Hospitalier Guillaume Régnier, Service Hospitalo-Universitaire de Psychiatrie, Rennes, France,Centre d'Investigation Clinique CIC-P INSERM 0203, Hôpital de Pontchaillou, Centre Hospitalier Universitaire de Rennes et Université de Rennes 1, Rennes, France,Service de Pharmacologie Clinique, CIC Inserm 0203, CHU de Rennes, Université de Rennes 1, Hôpital Pontchaillou, 2, rue Henri Le Guilloux, 35033 Rennes, France. E-mail:
| | - S Douabin
- Centre Hospitalier Guillaume Régnier, Service Hospitalo-Universitaire de Psychiatrie, Rennes, France
| | - A Esquevin
- EA-4712 Behavior and Basal Ganglia Unit, Université de Rennes 1, Rennes, France,Département de Neuroradiologie, Centre Eugène Marquis, Rennes, France
| | - M Vérin
- EA-4712 Behavior and Basal Ganglia Unit, Université de Rennes 1, Rennes, France
| | - T Dondaine
- EA-4712 Behavior and Basal Ganglia Unit, Université de Rennes 1, Rennes, France,Centre Hospitalier Guillaume Régnier, Service Hospitalo-Universitaire de Psychiatrie, Rennes, France
| | - G Robert
- EA-4712 Behavior and Basal Ganglia Unit, Université de Rennes 1, Rennes, France,Centre Hospitalier Guillaume Régnier, Service Hospitalo-Universitaire de Psychiatrie, Rennes, France
| | - D Drapier
- EA-4712 Behavior and Basal Ganglia Unit, Université de Rennes 1, Rennes, France,Centre Hospitalier Guillaume Régnier, Service Hospitalo-Universitaire de Psychiatrie, Rennes, France
| | - B Millet
- EA-4712 Behavior and Basal Ganglia Unit, Université de Rennes 1, Rennes, France,Centre Hospitalier Guillaume Régnier, Service Hospitalo-Universitaire de Psychiatrie, Rennes, France
| |
Collapse
|
38
|
Dondaine T, Robert G, Péron J, Grandjean D, Vérin M, Drapier D, Millet B. Biases in facial and vocal emotion recognition in chronic schizophrenia. Front Psychol 2014; 5:900. [PMID: 25202287 PMCID: PMC4141280 DOI: 10.3389/fpsyg.2014.00900] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2014] [Accepted: 07/29/2014] [Indexed: 01/26/2023] Open
Abstract
There has been extensive research on impaired emotion recognition in schizophrenia in the facial and vocal modalities. The literature points to biases toward non-relevant emotions for emotional faces but few studies have examined biases in emotional recognition across different modalities (facial and vocal). In order to test emotion recognition biases, we exposed 23 patients with stabilized chronic schizophrenia and 23 healthy controls (HCs) to emotional facial and vocal tasks asking them to rate emotional intensity on visual analog scales. We showed that patients with schizophrenia provided higher intensity ratings on the non-target scales (e.g., surprise scale for fear stimuli) than HCs for the both tasks. Furthermore, with the exception of neutral vocal stimuli, they provided the same intensity ratings on the target scales as the HCs. These findings suggest that patients with chronic schizophrenia have emotional biases when judging emotional stimuli in the visual and vocal modalities. These biases may stem from a basic sensorial deficit, a high-order cognitive dysfunction, or both. The respective roles of prefrontal-subcortical circuitry and the basal ganglia are discussed.
Collapse
Affiliation(s)
- Thibaut Dondaine
- EA 4712 'Behavior and Basal Ganglia' Laboratory, Université de Rennes 1 Rennes, France ; Psychiatry Unit, Guillaume Régnier Hospital Rennes, France
| | - Gabriel Robert
- EA 4712 'Behavior and Basal Ganglia' Laboratory, Université de Rennes 1 Rennes, France ; Psychiatry Unit, Guillaume Régnier Hospital Rennes, France
| | - Julie Péron
- 'Neuroscience of Emotion and Affective Dynamics' Laboratory, Department of Psychology, University of Geneva Switzerland ; Swiss Center for Affective Sciences, University of Geneva Switzerland
| | - Didier Grandjean
- 'Neuroscience of Emotion and Affective Dynamics' Laboratory, Department of Psychology, University of Geneva Switzerland ; Swiss Center for Affective Sciences, University of Geneva Switzerland
| | - Marc Vérin
- EA 4712 'Behavior and Basal Ganglia' Laboratory, Université de Rennes 1 Rennes, France ; Neurology Unit, University Hospital of Rennes France
| | - Dominique Drapier
- EA 4712 'Behavior and Basal Ganglia' Laboratory, Université de Rennes 1 Rennes, France ; Psychiatry Unit, Guillaume Régnier Hospital Rennes, France
| | - Bruno Millet
- EA 4712 'Behavior and Basal Ganglia' Laboratory, Université de Rennes 1 Rennes, France ; Psychiatry Unit, Guillaume Régnier Hospital Rennes, France
| |
Collapse
|
39
|
Nauczyciel C, Robic S, Dondaine T, Verin M, Robert G, Drapier D, Naudet F, Millet B. The nucleus accumbens: a target for deep brain stimulation in resistant major depressive disorder. J Mol Psychiatry 2013; 1:17. [PMID: 26019865 PMCID: PMC4445576 DOI: 10.1186/2049-9256-1-17] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2013] [Accepted: 09/18/2013] [Indexed: 01/21/2023] Open
Abstract
Objective This review aimed to investigate the therapeutic potential of Deep Brain Stimulation (DBS) for treating resistant Major Depressive Disorder (MDD). We explored the role of Nucleus accumbens (Nac) as a target for treatment. Method We made a systematic review of all studies examining the mechanisms of action of high frequency brain stimulation and the pathophysiology of MDD. We also reported all the studies exploring the therapeutic potential of DBS in MDD. Results As a central relay-structure, the Nac seems to play a central role in MDD symptomatology. We investigated its role as a primary target for DBS in depressed patients. Anatomically the Nac is at the centre of the interactions between dopaminergic, serotoninergic and glutamatergic systems. Functionally, the Nac is involved in both normal and abnormal reward processes and in anhedonia and loss of motivation. Due to its central location between the emotional system, the cognitive system and motor control system, the Nac seems to have a central role in mood and feeling regulation. Conclusion According to encouraging recent studies, DBS seems to be a promising technique in resistant MDD treatment.
Collapse
Affiliation(s)
- Cecilia Nauczyciel
- Academic Department of Adult Psychiatry, Guillaume Régnier Hospital, EA 4712 35000, Rennes, France
| | - Suzanne Robic
- Lyon Neuroscience Research Center INSERM U1028 - CNRS UMR 5292 Dynamics and Brain Cognition, 69675, Bron, France
| | - Thibaut Dondaine
- Rennes University Hospital Centre Research Unit EA 4712 Behavior and Basal Ganglia, 35000, Rennes, France
| | - Marc Verin
- Rennes University Hospital Centre Research Unit EA 4712 Behavior and Basal Ganglia, 35000, Rennes, France
| | - Gabriel Robert
- Academic Department of Adult Psychiatry, Guillaume Régnier Hospital, EA 4712 35000, Rennes, France ; Rennes University Hospital Centre Research Unit EA 4712 Behavior and Basal Ganglia, 35000, Rennes, France
| | - Dominique Drapier
- Academic Department of Adult Psychiatry, Guillaume Régnier Hospital, EA 4712 35000, Rennes, France ; Rennes University Hospital Centre Research Unit EA 4712 Behavior and Basal Ganglia, 35000, Rennes, France
| | - Florian Naudet
- Academic Department of Adult Psychiatry, Guillaume Régnier Hospital, EA 4712 35000, Rennes, France ; Rennes University Hospital Centre Research Unit EA 4712 Behavior and Basal Ganglia, 35000, Rennes, France
| | - Bruno Millet
- Academic Department of Adult Psychiatry, Guillaume Régnier Hospital, EA 4712 35000, Rennes, France ; Rennes University Hospital Centre Research Unit EA 4712 Behavior and Basal Ganglia, 35000, Rennes, France
| |
Collapse
|
40
|
Péron J, Dondaine T. [Emotion and basal ganglia (II): what can we learn from subthalamic nucleus deep brain stimulation in Parkinson's disease?]. Rev Neurol (Paris) 2012; 168:642-8. [PMID: 22901366 DOI: 10.1016/j.neurol.2012.06.012] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2012] [Revised: 06/18/2012] [Accepted: 06/20/2012] [Indexed: 11/16/2022]
Abstract
The subthalamic nucleus deep-brain stimulation Parkinson's disease patient model seems to represent a unique opportunity for studying the functional role of the basal ganglia and notably the subthalamic nucleus in human emotional processing. Indeed, in addition to constituting a therapeutic advance for severely disabled Parkinson's disease patients, deep brain stimulation is a technique, which selectively modulates the activity of focal structures targeted by surgery. There is growing evidence of a link between emotional impairments and deep-brain stimulation of the subthalamic nucleus. In this context, according to the definition of emotional processing exposed in the companion paper available in this issue, the aim of the present review will consist in providing a synopsis of the studies that investigated the emotional disturbances observed in subthalamic nucleus deep brain stimulation Parkinson's disease patients. This review leads to the conclusion that several emotional components would be disrupted after subthalamic nucleus deep brain stimulation in Parkinson's disease: subjective feeling, neurophysiological activation, and motor expression. Finally, after a description of the limitations of this study model, we discuss the functional role of the subthalamic nucleus (and the striato-thalamo-cortical circuits in which it is involved) in emotional processing. It seems reasonable to conclude that the striato-thalamo-cortical circuits are indeed involved in emotional processing and that the subthalamic nucleus plays a central in role the human emotional architecture.
Collapse
Affiliation(s)
- J Péron
- EA 4712 « behavior and basal ganglia », université Rennes 1, 2, Rennes, France
| | | |
Collapse
|
41
|
Robert G, Le Jeune F, Lozachmeur C, Drapier S, Dondaine T, Peron J, Travers D, Sauleau P, Millet B, Verin M, Drapier D. Apathy in patients with Parkinson disease without dementia or depression: A PET study. Neurology 2012; 79:1155-60. [DOI: 10.1212/wnl.0b013e3182698c75] [Citation(s) in RCA: 74] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
42
|
Dondaine T, Péron J. [Emotion and basal ganglia (I): what can we learn from Parkinson's disease?]. Rev Neurol (Paris) 2012; 168:634-41. [PMID: 22898560 DOI: 10.1016/j.neurol.2012.06.013] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2012] [Revised: 06/09/2012] [Accepted: 06/14/2012] [Indexed: 11/18/2022]
Abstract
Parkinson's disease provides a useful model for studying the neural substrates of emotional processing. The striato-thalamo-cortical circuits, like the mesolimbic dopamine system that modulates their function, are thought to be involved in emotional processing. As Parkinson's disease is histopathologically characterized by the selective, progressive and chronic degeneration of the nigrostriatal and mesocorticolimbic dopamine systems, it can therefore serve as a model for assessing the functional role of these circuits in humans. In the present review, after a definition of emotional processing from a multicomponential perspective, a synopsis of the emotional disturbances observed in Parkinson's disease is proposed. Note that the studies on the affective consequences of subthalamic nucleus deep brain stimulation in Parkinson's disease were excluded from this review because the subject of a companion paper in this issue. This review leads to the conclusion that several emotional components would be disrupted in Parkinson's disease: subjective feeling, neurophysiological activation, and motor expression. We then discuss the functional roles of the striato-thalamo-cortical and mesolimbic circuits, ending with the conclusion that both these pathways are indeed involved in emotional processing.
Collapse
Affiliation(s)
- T Dondaine
- EA 4712 « behavior and basal ganglia », université Rennes, Rennes, France.
| | | |
Collapse
|
43
|
Péron J, Dondaine T, Le Jeune F, Grandjean D, Vérin M. Emotional processing in Parkinson's disease: a systematic review. Mov Disord 2011; 27:186-99. [PMID: 22162004 DOI: 10.1002/mds.24025] [Citation(s) in RCA: 120] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2011] [Revised: 09/30/2011] [Accepted: 10/12/2011] [Indexed: 11/11/2022] Open
Abstract
Parkinson's disease provides a useful model for studying the neural substrates of emotional processing. The striato-thalamo-cortical circuits, like the mesolimbic dopamine system that modulates their function, are thought to be involved in emotional processing. As Parkinson's disease is histopathologically characterized by the selective, progressive, and chronic degeneration of the nigrostriatal and mesocorticolimbic dopamine systems, it can therefore serve as a model for assessing the functional role of these circuits in humans. In the present review, we begin by providing a synopsis of the emotional disturbances observed in Parkinson's disease. We then discuss the functional roles of the striato-thalamo-cortical and mesolimbic circuits, ending with the conclusion that both these pathways are indeed involved in emotional processing.
Collapse
Affiliation(s)
- Julie Péron
- Behavior and Basal Ganglia Research Unit (EM 425), University of Rennes 1, Hôpital Pontchaillou, CHU de Rennes, Rennes, France.
| | | | | | | | | |
Collapse
|
44
|
Rouaud T, Dondaine T, Drapier S, Haegelen C, Lallement F, Péron J, Raoul S, Sauleau P, Vérin M. Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation. Mov Disord 2010; 25:1839-46. [DOI: 10.1002/mds.23171] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
45
|
Péron J, Le Jeune F, Haegelen C, Dondaine T, Drapier D, Sauleau P, Reymann JM, Drapier S, Rouaud T, Millet B, Vérin M. Subthalamic nucleus stimulation affects theory of mind network: a PET study in Parkinson's disease. PLoS One 2010; 5:e9919. [PMID: 20360963 PMCID: PMC2847915 DOI: 10.1371/journal.pone.0009919] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2009] [Accepted: 02/10/2010] [Indexed: 11/19/2022] Open
Abstract
Background There appears to be an overlap between the limbic system, which is modulated by subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease (PD), and the brain network that mediates theory of mind (ToM). Accordingly, the aim of the present study was to investigate the effects of STN DBS on ToM of PD patients and to correlate ToM modifications with changes in glucose metabolism. Methodology/Principal Findings To this end, we conducted 18FDG-PET scans in 13 PD patients in pre- and post-STN DBS conditions and correlated changes in their glucose metabolism with modified performances on the Eyes test, a visual ToM task requiring them to describe thoughts or feelings conveyed by photographs of the eye region. Postoperative PD performances on this emotion recognition task were significantly worse than either preoperative PD performances or those of healthy controls (HC), whereas there was no significant difference between preoperative PD and HC. Conversely, PD patients in the postoperative condition performed within the normal range on the gender attribution task included in the Eyes test. As far as the metabolic results are concerned, there were correlations between decreased cerebral glucose metabolism and impaired ToM in several cortical areas: the bilateral cingulate gyrus (BA 31), right middle frontal gyrus (BA 8, 9 and 10), left middle frontal gyrus (BA 6), temporal lobe (fusiform gyrus, BA 20), bilateral parietal lobe (right BA 3 and right and left BA 7) and bilateral occipital lobe (BA 19). There were also correlations between increased cerebral glucose metabolism and impaired ToM in the left superior temporal gyrus (BA 22), left inferior frontal gyrus (BA 13 and BA 47) and right inferior frontal gyrus (BA 47). All these structures overlap with the brain network that mediates ToM. Conclusion/Significance These results seem to confirm that STN DBS hinders the ability to infer the mental states of others and modulates a distributed network known to subtend ToM.
Collapse
Affiliation(s)
- Julie Péron
- Clinique Neurologique, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- * E-mail:
| | - Florence Le Jeune
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Service de Médecine Nucléaire, Centre Anti-cancéreux Eugène Marquis de Rennes, Rennes, France
| | - Claire Haegelen
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Service de Neurochirurgie, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
| | - Thibaut Dondaine
- Clinique Neurologique, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Service Hospitalo-Universitaire de Psychiatrie Adulte, Centre Hospitalier Guillaume Régnier de Rennes, Rennes, France
| | - Dominique Drapier
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Service Hospitalo-Universitaire de Psychiatrie Adulte, Centre Hospitalier Guillaume Régnier de Rennes, Rennes, France
| | - Paul Sauleau
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Service des Explorations Fonctionnelles, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
| | - Jean-Michel Reymann
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Centre d'Investigation Clinique, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
| | - Sophie Drapier
- Clinique Neurologique, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
| | - Tiphaine Rouaud
- Clinique Neurologique, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
| | - Bruno Millet
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Service Hospitalo-Universitaire de Psychiatrie Adulte, Centre Hospitalier Guillaume Régnier de Rennes, Rennes, France
| | - Marc Vérin
- Clinique Neurologique, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
- Unité de Recherche Universitaire-EM 425 «Behavior and Basal Ganglia», Université Rennes 1, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
| |
Collapse
|